Skip to main content
Aging Medicine logoLink to Aging Medicine
. 2024 Jan 10;6(4):386–426. doi: 10.1002/agm2.12277

Temporal trends of thyroid cancer between 2010 and 2019 in Asian countries by geographical region and SDI, comparison with global data

Fatemeh Rezaei 1, Afrooz Mazidimoradi 2, Zahra Pasokh 3, Seyed Parsa Dehghani 4, Leila Allahqoli 5, Hamid Salehiniya 6,
PMCID: PMC10792336  PMID: 38239716

Abstract

Objective

This study aims to describe temporal trends of thyroid cancer (ThC) from 2010 to 2019, in Asian countries by geographical region and sociodemographic index, compared with global data.

Method

Annual case data and age‐standardized rates (ASRs) of epidemiological indicators of ThC cancer data were collected from the 2019 Global Burden of Disease (GBD) study from 2010 to 2019 in 49 countries and territories in Asia. The relative difference (%) between years was used to show comparative variations of ASRs for the indicators studied. The female/male ratio was calculated by dividing female ASRs by male ASRs. Also, these rates were compared between the age group ≥70 years old and younger age groups.

Results

In 2019, more than 50% of ThC cases and deaths occurred in Asian countries. A total of 53% of ThC patients lived in Asia and more than 60% of the global burden of ThC was imposed on Asian countries. From 2010 to 2019, incidences, deaths, prevalence cases, and DALYs number of ThC cancer increased over 1.28‐, 1.26‐, 1.3‐, and 1.2‐fold, in Asia, respectively. During this period, the age‐standardized incidence rate (ASIR) and the age‐standardized prevalence rate (ASPR) of ThC cancer increased by 5% and 8%, respectively, while the age‐standardized death rate (ASDR) and the age‐standardized DALYs rate (DALYs ASR) of ThC cancer decreased by 6% and 4%, respectively. These trends are different from what happens in other continents. In 2019, age‐specific incidence, death, prevalence, and DALY cases of ThC cancer were peaking at 50–54, 75–79, 50–54, and 55–59 years, respectively. In 2019, the highest ASIR and ASPR of ThC cancer was observed in high‐income Asia Pacific countries and the highest ASDR and DALYs ASR in Southeast Asia countries. Only high‐income Asia Pacific countries experienced a decreasing trend in ASIR and ASPR from 2010 to 2019. ASDR and DALYs ASR have the highest decreasing trend in high‐income Asia Pacific. In 2019, among high SDI Asian countries, the Republic of Korea had the highest ASIR and ASPR, and Brunei Darussalam had the highest ASDR and DALYs ASR. The highest ASIR, ASDR, ASPR, and DALY ASR of ThC cancer was found in Lebanon and Malaysia (high‐middle SDIs), Vietnam (middle SDIs), and Cambodia and Palestine (low‐middle SDIs). Among low SDI Asian countries, Pakistan had the highest ASIR, ASDR, ASPR, and DALY ASR of ThC cancer. All indicators for most countries were higher in women than men.

Conclusion

More than half of the burden of thyroid cancer is imposed on the residents of the Asian continent. Although the incidence and prevalence of this cancer in Asian countries is lower than that of the world, America, and Europe, the highest rate of death from thyroid cancer occurs in Asia and they witness the highest burden of the disease. Therefore, it seems that implementing early detection strategies and increasing access to treatment facilities in Asia is one of the necessities of thyroid cancer control in its residents.

Keywords: Asia, burden, death, incidence, prevalence, thyroid cancer


More than half of the burden of thyroid cancer is imposed on the residents of the Asian continent. Although the incidence and prevalence of this cancer in Asian countries is lower than that of the world, America and Europe, the highest rate of death from thyroid cancer occurs in Asia and they witness the highest burden of the disease. Therefore, it seems that implementing early detection strategies and increasing access to treatment facilities in Asia is one of the necessities of thyroid cancer control in its residents.

graphic file with name AGM2-6-386-g008.jpg

1. INTRODUCTION

Thyroid cancer (ThC) is a common form of endocrine cancer worldwide, 1 with adult women being the most affected. It ranks fifth among the most frequently diagnosed cancers in women globally and second in women above the age of 50. 1 Over the past three decades, the incidence of thyroid cancer has been on the rise worldwide. 2 The global age‐standardized incidence rate of thyroid cancer increased by 20% from 1990 to 2013, with low‐income countries recording a higher rate than high‐income countries (33% vs. 19%). 3 In 2020, according to GLOBOCAN estimates, there were 586,000 new cases of thyroid cancer globally, making it the ninth most common cancer. 4

It's interesting to note that there has been an increasing number of thyroid tumors reported worldwide. While the exact cause is unclear, it is believed to be due to various factors such as general screening, thyroid sonography, and aspiration biopsies that can detect small tumors. 5 However, many experts believe these higher‐quality screening methods alone cannot explain the entire trend, and other risk factors are also being studied. 6

While certain ThC risk factors like patient age, sex, race or ethnicity, and hereditary predisposition cannot be modified, 7 other factors can. These include radiation exposure 5 ; iodine intake 5 ; thyroid stimulating hormone (TSH) 5 ; environmental pollutants like several industrialized food additives, such as nitrates from cured meat and some vegetables, which can challenge iodine uptake and potentially alter thyroid function 8 , 9 ; BMI 10 ; lifestyle; and diet. 11

It is necessary to mention the incidence of ThC varies in different geographical regions. Its incidence is more remarkable in high‐income countries compared with low‐income and middle‐income countries for both sexes. 12 Thus, this study aims to describe temporal trends of ThC from 2010 to 2019, in Asian countries by geographical region and sociodemographic index, compared with global data.

2. METHODS

2.1. Data source

The incidence, mortality, prevalence, and burden data for ThC were extracted from the GBD 2019 study for the following regions: 49 Asian countries, 6 global burden of disease (GBD) regions, worldwide, and 4 continents. Data were extracted from the Global Health Data Exchange (GHDx) using the GBD 2019 query tool (http://ghdx.healthdata.org/gbd‐resultstool) based on the International Classification of Diseases 10 (ICD‐10 code 73 for ThC). In GBD, epidemiological indicators included incidence, death, prevalence, years of life lost (YLL), years lived with disability (YLD), and disability‐adjusted life years (DALY) by time, location, gender, and age group for 204 countries and territories from 1990 to 2019 is estimated to provide a comparative assessment of health loss due to 364 diseases and injuries. 13

In this study, the data were extracted for various classifications of Asian countries based on a sociodemographic index (SDI) and six GBD regions of Asia from 2010 to 2019. The data were then compared with worldwide and other continental data, specifically North Africa and the Middle East, where 15 out of 21 GBD countries belong to West Asia. Additionally, two Southeast Asian countries were from Africa. 14 , 15

The GBD has developed a standardized international form of quality‐adjusted life year (QALY), known as DALY. DALYs for a given condition within a population are equal to the sum of YLLs and YLDs of known severity and duration. One DALY represents the loss of an equivalent 1 year of full health due to premature death and years lived with a disability of specific severity and duration. “Premature” death is a death that occurs at an age when a person's death is not expected. The expected age of death of a person is calculated based on the expected mortality for a certain age in a population standardized to the population of Japan, which has the longest lifetime at birth in the world. 15

The SDI is a composite indicator of a country's lag‐distributed income per capita, average educational attainment of people aged 15 years and older, and the total fertility rate (in people aged <25 years). The geometric average of these three indicators is used to calculate the SDI. The SDI reflects the levels of social and economic conditions that can affect health outcomes in a given location. Countries and territories were categorized into five groups based on their SDI values: low SDI (<0.45), low‐middle SDI (≥0.45 and <0.61), middle SDI (≥0.61 and <0.69), high‐middle SDI (≥0.69 and <0.80), and high SDI (≥0.80). 16

The age‐standardized rate (ASR) is a calculation that takes into account the differences in age distribution between populations by applying the rates for each population to a standardized population. It is a weighted average of the age‐specific rates per 100,000 persons within the corresponding age groups of the WHO standard population. 17

2.2. Ethical considerations

This study was approved by the Ethics Committee of the Jahrom University of Medical Sciences in Iran (IR.JUMS.REC.1401.094 code). In this study, informed consent was not required due to the use of the anonymous online dataset.

2.3. Statistical analysis

In this study, the incidence, prevalence, deaths, DALY, and age‐standardized rates were expressed per 100,000 population to eliminate the influence of the composition of different age groups within populations. The data are reported as values with 95% confidence intervals (CI). Selected epidemiological indicators are presented separately for each classification system.

The relative difference (%) between years was used to demonstrate the comparative changes in age‐standardized rates. The relative differences were calculated by dividing the value of the absolute difference by the value of the source year, which is multiplied by 100. The F/M ratio was computed by dividing the female ASRs by the male ASRs of each epidemiological index. The definition of what has been used is accessible via https://www.healthdata.org/terms‐defined and https://www.healthdata.org/gbd/.

3. RESULTS

3.1. Incidence rate of ThC in Asia

3.1.1. Compared with global data and continents

In Asia, the number of ThC incidences increased from 98,632 (95% CI: 83,838–104,253) in 2010 to 127,008 (95% CI: 111,149–139,720) in 2019, which is over a 1.28‐fold increase. In 2019, more than 54% (127,008/233,847) of ThC cases happened in Asian countries.

During this period, the ASIR of ThC had a 5% change, increasing from 2.44 (95% CI: 2.07–2.57) per 100,000 in 2010 to 2.56 (95% CI: 2.23–2.82) per 100,000 in 2019. Similarly at the same time, this rate globally increased by 1% and in Africa by 14%. But this rate decreased in America by 1% and in Europe by 3%.

In Asian men, the number of ThC incidences increased from 29,253 (95% CI: 24,129–31,446) in 2010 to 40,021 (95% CI: 33,634–45,216) in 2019, which is approximately a 73.1% increase.

In 2019, more than 31.5% (40,021/127,008) of Asian ThC new cases occurred in Asian men, which included 52.6% (40,021/76,014) of global male ThC incidence cases.

During this period, the ASIR of ThC had a 10% change, increasing from 1.50 (95% CI: 1.23–1.61) per 100,000 in 2010 to 1.65 (95% CI: 1.39–1.86) per 100,000 in 2019. Also at the same time, this rate globally increased by 5%, in America by 3%, and in Africa by 19%, while Europe had a stable trend.

In Asian women, the number of ThC incidences increased from 69,379 (95% CI: 56,407–74,309) in 2010 to 86,988 (95% CI: 73,241–97,296) in 2019, which is over a 1.25‐fold increase. In 2019, approximately 68.5% (86,988/127,008) of new Asian ThC cases occurred in Asian women, which included 55.1% (86,988/157,833) of global female THC incidence cases. During this period, the ASIR of ThC had a 3% change, increasing from 3.38 (95% CI: 2.77–3.62) per 100,000 in 2010 to 3.49 (95% CI: 2.93–3.90) per 100,000 in 2019. At the same time, this rate increased in Africa by 12%, while this rate globally decreased by 1%, in Europe by 5%, and in American countries by 3%. More details are presented in Table 1.

TABLE 1.

The comparing incidence, death, prevalence, and burden rates of thyroid cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019 (Both genders).

Location Incidence Death Prevalence DALY
2010 2019 % change 2010–2019 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000
Global 191,197 2.80 233,847 2.83 0.01 37,268 0.60 45,576 0.57 −0.05 1,496,364 21.47 1,831,760 22.02 0.03 1,045,885 15.65 1,231,841 14.98 −0.04
(171,483–197,888) (2.51–2.9) (211,637–252,807) (2.56–3.06) (−0.06–0.09) (33,797–38,957) (0.54–0.62) (41,290–48,775) (0.51–0.61) (−0.09–0.01) (1,342,408–1,549,790) (19.27–22.23) (1,656,127–1,985,013) (19.91–23.86) (−0.05–0.11) (943,436–1,104,349) (14.12–16.52) (1,113,585–1,327,064) (13.55–16.14) (−0.1–0.01)
Continents
Africa 9483 1.44 14,333 1.64 0.14 2738 0.56 3576 0.56 0.00 67,759 8.95 107,585 10.99 0.23 92,094 15.09 119,320 14.92 −0.01
(7765–10,709) (1.22–1.61) (11,677–17,056) (1.37–1.92) (0.03–0.28) (2362–3084) (0.49–0.63) (3005–4128) (0.48–0.64) (−0.07–0.08) (54,378–77,060) (7.39–10.09) (86,042–128,864) (9.05–13.02) (0.08–0.4) (77,386–104,415) (12.95–16.99) (98,903–140,470) (12.45–17.33) (−0.1–0.09)
America 37,686 3.78 45,225 3.75 −0.01 5769 0.58 7288 0.57 −0.01 304,159 30.52 362,056 30.27 −0.01 150,721 15.20 183,206 14.90 −0.02
(36,327–38,642) (3.65–3.87) (40,289–50,631) (3.33–4.19) (−0.11–0.1) (5320–5997) (0.53–0.6) (6647–7824) (0.52–0.61) (−0.06–0.04) (294,873–311,885) (29.6–31.3) (321,836–405,339) (26.88–33.93) (−0.11–0.11) (141,484–159,249) (14.27–16.06) (168,386–199,457) (13.7–16.22) (−0.08–0.05)
Asia 98,632 2.44 127,008 2.56 0.05 21,405 0.63 26,982 0.59 −0.06 759,981 17.94 982,341 19.42 0.08 624,971 16.10 750,984 15.39 −0.04
(83,838–104,253) (2.07–2.57) (111,149–139,720) (2.23–2.82) (−0.04–0.15) (18,846–22,632) (0.55–0.66) (23,978–29,391) (0.52–0.64) (−0.13–0.01) (640,546–805,950) (15.12–18.98) (857,344–1,082,418) (16.93–21.38) (−0.02–0.19) (545,913–666,046) (14.08–17.12) (665,083–819,813) (13.6–16.79) (−0.11–0.03)
Europe 45,168 3.97 47,009 3.84 −0.03 7307 0.54 7670 0.49 −0.09 362,713 32.79 377,694 31.99 −0.02 176,830 14.40 176,829 12.99 −0.10
(43,086–46,451) (3.81–4.08) (42,592–52,230) (3.48–4.26) (−0.12–0.07) (6758–7566) (0.5–0.56) (6955–8203) (0.45–0.52) (−0.13 to −0.04) (347,378–373,148) (31.47–33.73) (341,009–419,952) (28.88–35.47) (−0.11–0.08) (165,890–187,139) (13.55–15.32) (162,099–191,586) (11.88–14.14) (−0.15 to −0.04)
Asian GBD regions
Central Asia 975 1.40 1467 1.69 0.21 243 0.43 309 0.45 0.05 7288 9.77 11,454 12.37 0.27 7261 11.16 9231 11.46 0.03
(925–1032) (1.33–1.47) (1306–1650) (1.51–1.89) (0.08–0.35) (233–254) (0.41–0.45) (278–341) (0.4–0.49) (−0.05–0.14) (6860–7770) (9.19–10.39) (10,131–12,975) (10.95–13.97) (0.12–0.43) (6900–7650) (10.65–11.73) (8203–10,321) (10.27–12.79) (−0.08–0.13)
East Asia 31,302 1.85 41,580 2.11 0.14 6215 0.43 7621 0.40 −0.08 246,288 14.05 330,694 16.65 0.18 169,689 10.54 197,337 9.86 −0.07
(28,108–35,140) (1.67–2.07) (34,751–50,204) (1.77–2.54) (−0.05–0.36) (5559–6796) (0.38–0.47) (6346–8874) (0.33–0.46) (−0.21–0.07) (220,561–279,945) (12.62–15.94) (274,743–403,528) (13.89–20.23) (−0.02–0.43) (151,959–186,977) (9.47–11.6) (165,224–228,530) (8.3–11.35) (−0.2–0.09)
High‐income Asia Pacific 20,055 7.51 15,660 4.98 −0.34 2564 0.68 2754 0.53 −0.22 166,514 64.62 123,548 42.29 −0.35 56,207 17.94 49,019 12.46 −0.31
(13,617–21,957) (4.75–8.31) (13,134–18,056) (4.19–5.79) (−0.44 to −0.05) (1981–2795) (0.52–0.73) (2128–3071) (0.43–0.58) (−0.26 to −0.1) (110,557–182,829) (40.15–71.7) (105,012–142,979) (35.62–49.33) (−0.46 to −0.05) (41,048–62,003) (12.37–20.06) (41,648–54,668) (10.69–13.99) (−0.36 to −0.11)
North Africa and Middle East 11,873 2.81 19,253 3.46 0.23 1705 0.54 2290 0.54 0.00 98,458 22.11 163,048 28.17 0.27 54,929 14.62 74,180 14.88 0.02
(9876–13,126) (2.45–3.08) (15,675–22,281) (2.89–3.96) (0.11–0.36) (1548–1994) (0.49–0.67) (1981–2669) (0.47–0.66) (−0.09–0.08) (79,166–109,564) (18.36–24.41) (130,172–189,792) (22.9–32.54) (0.15–0.42) (48,453–61,216) (13.2–16.54) (62,526–86,119) (12.81–17.09) (−0.07–0.11)
South Asia 21,321 1.62 31,534 1.90 0.17 6885 0.65 9196 0.65 0.00 147,955 10.15 226,467 12.80 0.26 231,768 18.49 291,575 18.33 −0.01
(18,203–23,510) (1.39–1.78) (26,591–36,439) (1.61–2.19) (0.02–0.36) (6105–7550) (0.57–0.72) (7978–10,477) (0.56–0.74) (−0.12–0.14) (123,964–164,187) (8.54–11.23) (189,126–263,769) (10.66–14.9) (0.08–0.48) (203,824–253,204) (16.42–20.24) (254,403–330,796) (15.98–20.88) (−0.13–0.12)
Southeast Asia 18,339 3.32 25,581 3.72 0.12 4624 1.06 5862 1.02 −0.04 136,412 22.74 194,899 26.85 0.18 132,702 26.41 164,304 25.34 −0.04
(14,850–20,486) (2.73–3.67) (20,569–29,886) (3.01–4.32) (−0.01–0.28) (3928–5034) (0.91–1.15) (4999–6646) (0.88–1.15) (−0.13–0.05) (108,547–154,350) (18.3–25.63) (153,975–230,803) (21.32–31.59) (0.03–0.37) (109,066–146,918) (22.05–29.03) (136,534–187,956) (21.37–28.88) (−0.14–0.06)

3.1.2. Age distribution

In 2019, age‐specific incidence cases of ThC were peaking at +85 in both males and females. In all age groups, the incidence cases of ThC in females were higher (Figure 1). In 2019, 19,624 new cases of ThC were diagnosed in people aged ≥70 years in Asia, accounting for 15.45% of ThC cases in all ages. This rate was 17.67% in men and 14.43% in women. Meanwhile, in the world, 40,773 new cases of ThC have been diagnosed in people ≥70 years, which includes 17.44% of ThC cases in all ages. This rate was 18.65% in men and 16.85% in women. Overall, 48.13% of new cases of ThC were detected in the elderly aged ≥70 years in Asia (Table 2).

FIGURE 1.

FIGURE 1

Age‐specific incidence cases of ThC cancer among gein Asia, 2019.

TABLE 2.

Comparison of incidence, death, prevalence, and DALYs number of thyroid cancer in age <70 and ≥70 in Asia with global data.

Location Measure Male Female Both
<70 ≥70 <70 ≥70 <70 ≥70
Global Incidence 61,836 14,178 131,238 26,595 193,073 40,773
(55,017–67,624) (12,535–15,467) (115,909–144,055) (23,177–29,299) (174,684–208,931) (36,131–44,073)
Death 10,115 8520 13,163 13,778 23,278 22,298
(9168–11,076) (7442–9244) (11,292–14,400) (11,872–15,017) (21,116–25,069) (19,518–23,859)
Prevalence 507,398 55,344 1,139,795 129,223 1,647,193 184,567
(450,902–555,879) (48,199–61,515) (1,005,830–1,253,793) (113,353–142,871) (1,484,083–1,785,830) (164,339–200,974)
DALY 385,618 124,224 527,437 194,563 913,055 318,786
(347,249–421,224) (110,564–135,121) (450,033–584,525) (170,961–211,812) (819,893–990,759) (283,892–342,040)
Asia Incidence 32,947 7073 74,437 12,550 107,384 19,624
(27,658–37,464) (6025–7958) (62,109–83,816) (10,637–14,334) (93,399–118,277) (16,873–21,594)
Death 6392 5074 8191 7325 14,583 12,399
(5529–7225) (4246–5689) (6691–9235) (6153–8218) (12,836–15,995) (10,705–13,587)
Prevalence 264,795 20,547 643,274 53,725 908,069 74,272
(221,360–301,754) (17,471–23,667) (537,321–726,363) (45,037–62,060) (786,711–1,001,776) (63,777–83,495)
DALY 243,304 73,517 329,588 104,575 107,384 178,092
(209,750–272,823) (62,506–82,547) (270,330–372,713) (88,602–116,807) (93,399–118,277) (155,623–194,846)

3.1.3. Within Asian regions

In 2019, the highest ASIR of ThC was observed in high‐income Asia Pacific countries (4.98 (95% CI: 4.19–5.79)), with a 34% decrease compared with 2010. All Asian regions experienced an increasing trend from 12% (Southeast Asia) to 23% (North Africa and Middle East) from 2010 to 2019, except high‐income Asia Pacific countries that reported a decreasing trend of 34%.

In men, the highest ASIR of ThC was observed in high‐income Asia Pacific countries (2.75 (95% CI: 2.21–3.30)), with a 30% decrease compared with 2010. Other Asian regions experienced an increasing trend from 16% (South Asia) to 34% (North Africa and Middle East) from 2010 to 2019.

In women, the highest ASIR of ThC was observed in high‐income Asia Pacific countries (7.20 (95% CI: 5.84–8.59)), with a 35% decrease compared with 2010. Other Asian regions experienced an increasing trend from 9% (East Asia) to 20% (Central Asia and North Africa and the Middle East).

3.1.4. Based on SDI

Among high SDI Asian countries, the Republic of Korea (6.77) and Saudi Arabia (5.98) have the highest ASIR of ThC, and Qatar (2.93) and Cyprus (3.13) have the lowest rate. In this group, Brunei Darussalam (3%), Taiwan (Province of China) (5%), Saudi Arabia (31%), and the United Arab Emirates (11%) reported an upward trend, and other countries reported a downward trend from 2% (Kuwait) to 54% (Republic of Korea) from 2010 to 2019.

Among high‐middle SDI Asian countries, Lebanon (7.95) has the highest ASIR of ThC, and Georgia (2.46) has the lowest rate. In this group, Bahrain and Oman reported an 11% and 13% decrease in ASIR from 2010 to 2019, respectively. Other countries reported an upward trend from 3% (Turkey) to 27% (Lebanon and Sri Lanka).

Among middle SDI Asian countries, Vietnam (7.25) has the highest ASIR of THC, and Uzbekistan (0.93) and the Syrian Arab Republic (0.97) have the lowest rate. In this group, Thailand recorded a downward trend of 4%. Other countries had an upward trend from 6% (Indonesia) to 82% (Armenia) from 2010 to 2019. Among low‐middle SDI Asian countries, Cambodia (3.61) has the highest ASIR of ThC, and Tajikistan (0.48) has the lowest rate. In this group, all countries had an upward trend from 2% (Mongolia) to 49% (Palestine) from 2010 to 2019, except for the Democratic People's Republic of Korea, which experienced a downward trend of 1%. Among low SDI Asian countries, Pakistan (2.96) has the highest ASIR of ThC, and Yemen (1.86) has the lowest rate. In this group, all countries experienced an upward trend of 11% (Afghanistan) to 33% (Nepal) from 2010 to 2019. More details are presented in Table 3.

TABLE 3.

The incidence distribution of thyroid cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019, by geographical region and SDI.

Location SDI 2019 Both Male Female F/M Ratio
2010 2019 % change 1990–2010 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000
High SDI
Brunei Darussalam 0.823 14 4.92 20 5.09 0.03 3 2.06 4 2.23 0.08 12 7.73 16 8.00 0.04 3.59
(12–17) (4.03–5.7) (16–25) (4.08–6.15) (−0.15–0.25) (2–3) (1.7–2.42) (3–5) (1.78–2.76) (−0.16–0.36) (9–14) (6.23–9.26) (12–21) (6.2–10.12) (−0.18–0.31)
Cyprus 0.841 50 3.64 56 3.13 −0.14 20 3.12 24 2.86 −0.08 30 4.12 32 3.38 −0.18 1.18
(41–57) (3.02–4.11) (45–68) (2.55–3.85) (−0.28–0.03) (16–25) (2.42–3.75) (17–31) (2.06–3.74) (−0.3–0.21) (24–35) (3.42–4.92) (25–42) (2.66–4.58) (−0.36–0.06)
Israel 0.803 381 4.60 436 4.22 −0.08 134 3.43 157 3.21 −0.06 247 5.65 279 5.14 −0.09 1.60
(341–424) (4.09–5.12) (331–564) (3.2–5.47) (−0.31–0.2) (106–154) (2.73–3.96) (114–211) (2.33–4.32) (−0.33–0.28) (213–283) (4.87–6.51) (207–370) (3.83–6.83) (−0.33–0.22)
Japan 0.87 10,521 4.72 10,134 4.22 −0.11 2912 2.73 2882 2.49 −0.09 7609 6.63 7251 5.90 −0.11 2.37
(9499–11,241) (4.38–5.05) (8281–12,092) (3.5–5.09) (−0.25–0.08) (2550–3202) (2.44–3.01) (2207–3695) (1.93–3.21) (−0.29–0.16) (6842–8221) (6.09–7.17) (5694–8919) (4.67–7.36) (−0.29–0.12)
Kuwait 0.851 87 3.88 149 3.79 −0.02 24 1.82 54 2.47 0.36 62 7.24 95 5.61 −0.22 2.27
(76–98) (3.48–4.34) (120–186) (3.09–4.67) (−0.21–0.19) (20–29) (1.55–2.1) (41–73) (1.87–3.23) (0.04–0.78) (53–73) (6.22–8.33) (71–129) (4.37–7.34) (−0.4–0.01)
Qatar 0.83 34 3.39 59 2.93 −0.14 17 1.88 29 1.76 −0.06 17 7.75 30 6.66 −0.14 3.79
(27–43) (2.74–4.08) (41–85) (2.19–3.95) (−0.34–0.13) (12–23) (1.33–2.52) (19–41) (1.17–2.47) (−0.37–0.31) (13–23) (6–9.88) (20–49) (4.74–9.53) (−0.38–0.21)
Republic of Korea 0.878 9263 14.62 5209 6.77 −0.54 2288 7.19 1321 3.37 −0.53 6975 21.88 3888 10.25 −0.53 3.04
(2875–10,905) (4.54–17.21) (3564–6623) (4.46–8.69) (−0.65 to −0.01) (719–2774) (2.41–8.57) (883–1747) (2.27–4.41) (−0.65–0) (2143–8474) (6.43–26.75) (2596–5134) (6.37–13.62) (−0.66–0.12)
Saudi Arabia 0.805 1037 4.55 2259 5.98 0.31 274 2.17 708 3.23 0.49 763 8.10 1551 10.20 0.26 3.16
(762–1289) (3.65–5.39) (1528–3157) (4.36–7.91) (−0.02–0.7) (215–350) (1.77–2.69) (491–1047) (2.35–4.38) (0.11–0.95) (479–973) (6.03–10) (886–2292) (6.88–14.25) (−0.09–0.7)
Singapore 0.861 257 4.36 298 3.73 −0.14 58 2.04 76 1.94 −0.05 199 6.84 222 5.68 −0.17 2.92
(225–291) (3.86–4.91) (226–381) (2.85–4.75) (−0.34–0.1) (49–69) (1.74–2.44) (57–104) (1.47–2.63) (−0.27–0.25) (170–230) (5.88–7.85) (166–288) (4.25–7.44) (−0.37–0.08)
Taiwan (Province of China) 0.868 1443 4.79 1737 5.01 0.05 452 2.99 578 3.35 0.12 992 6.54 1159 6.61 0.01 1.97
(1288–1615) (4.3–5.34) (1310–2357) (3.73–6.83) (−0.22–0.42) (382–528) (2.56–3.45) (424–792) (2.48–4.56) (−0.18–0.51) (864–1149) (5.71–7.53) (850–1581) (4.8–9.16) (−0.27–0.41)
United Arab Emirates 0.88 189 3.50 444 3.88 0.11 135 2.75 314 3.53 0.28 54 5.15 130 4.95 −0.04 1.40
(112–270) (1.94–5.08) (229–710) (2.1–5.93) (−0.16–0.49) (70–205) (1.45–4.11) (147–522) (1.72–5.61) (−0.07–0.75) (36–77) (2.63–7.95) (67–207) (2.58–7.75) (−0.29–0.41)
High‐middle SDI
Bahrain 0.751 28 3.85 45 3.43 −0.11 7 1.48 14 1.46 −0.01 21 6.97 32 6.53 −0.06 4.46
(22–33) (2.61–4.56) (34–58) (2.56–4.34) (−0.3–0.18) (6–9) (1.17–1.8) (9–19) (1.05–1.93) (−0.28–0.33) (15–25) (4.49–8.54) (23–42) (4.63–8.47) (−0.28–0.27)
Georgia 0.702 102 1.99 123 2.46 0.24 21 0.92 29 1.28 0.40 81 2.90 94 3.50 0.21 2.73
(89–115) (1.73–2.25) (96–150) (1.9–3.01) (−0.02–0.54) (17–25) (0.73–1.08) (18–37) (0.79–1.61) (0.02–0.78) (68–93) (2.46–3.38) (73–114) (2.71–4.34) (−0.07–0.54)
Jordan 0.731 160 3.31 321 3.60 0.09 39 1.58 93 1.88 0.19 121 5.20 229 5.58 0.07 2.97
(132–194) (2.77–3.98) (249–417) (2.83–4.69) (−0.13–0.35) (31–47) (1.27–1.9) (67–125) (1.39–2.53) (−0.12–0.59) (96–154) (4.18–6.45) (164–319) (4.04–7.71) (−0.19–0.42)
Kazakhstan 0.723 407 2.50 580 3.00 0.20 93 1.29 128 1.47 0.14 314 3.51 452 4.29 0.22 2.92
(369–451) (2.28–2.77) (480–701) (2.48–3.59) (−0.01–0.45) (81–110) (1.13–1.51) (101–168) (1.17–1.96) (−0.09–0.44) (277–353) (3.11–3.92) (369–555) (3.5–5.23) (−0.01–0.51)
Lebanon 0.708 261 6.25 431 7.95 0.27 67 3.40 123 4.91 0.44 194 8.77 308 10.67 0.22 2.17
(208–329) (4.94–7.89) (306–582) (5.67–10.79) (−0.04–0.61) (52–85) (2.62–4.3) (85–164) (3.38–6.48) (0.09–0.89) (142–254) (6.49–11.55) (204–443) (7.12–15.42) (−0.11–0.63)
Malaysia 0.737 872 3.67 1379 4.49 0.22 212 1.79 380 2.46 0.38 661 5.60 999 6.63 0.19 2.70
(762–1014) (3.22–4.28) (1025–1813) (3.35–5.88) (−0.08–0.59) (176–256) (1.5–2.15) (278–510) (1.8–3.26) (0.02–0.83) (558–788) (4.77–6.69) (718–1343) (4.8–8.9) (−0.13–0.59)
Oman 0.783 73 3.75 112 3.26 −0.13 21 1.85 37 1.67 −0.09 52 6.59 74 5.97 −0.09 3.57
(53–86) (2.9–4.32) (82–146) (2.53–3.97) (−0.28–0.07) (17–25) (1.54–2.17) (25–54) (1.2–2.21) (−0.33–0.22) (34–64) (4.54–7.92) (48–102) (4.25–7.8) (−0.29–0.2)
Sri Lanka 0.69 579 2.73 886 3.47 0.27 156 1.60 242 2.05 0.28 423 3.73 644 4.74 0.27 2.32
(503–714) (2.4–3.35) (622–1273) (2.44–4.97) (−0.1–0.77) (131–190) (1.37–1.92) (164–342) (1.4–2.87) (−0.14–0.75) (355–551) (3.14–4.84) (444–949) (3.27–6.99) (−0.11–0.82)
Turkey 0.748 2537 3.44 3271 3.54 0.03 783 2.15 1130 2.46 0.15 1754 4.65 2141 4.55 −0.02 1.85
(2118–3013) (2.9–4.08) (2493–4322) (2.72–4.67) (−0.23–0.37) (643–962) (1.77–2.63) (837–1599) (1.83–3.52) (−0.17–0.54) (1393–2120) (3.71–5.6) (1597–2881) (3.4–6.13) (−0.29–0.34)
Middle SDI
Armenia 0.689 46 1.28 91 2.33 0.82 14 0.91 27 1.58 0.74 32 1.59 64 2.95 0.86 1.87
(42–56) (1.16–1.55) (74–110) (1.92–2.79) (0.42–1.25) (12–23) (0.79–1.38) (22–33) (1.27–1.92) (0.12–1.19) (28–36) (1.41–1.79) (51–78) (2.39–3.6) (0.42–1.33)
Azerbaijan 0.683 141 1.59 195 1.75 0.11 33 0.82 50 0.98 0.20 108 2.27 144 2.46 0.08 2.50
(117–170) (1.34–1.91) (149–250) (1.37–2.23) (−0.11–0.38) (26–42) (0.67–1.03) (34–69) (0.69–1.33) (−0.1–0.56) (86–135) (1.83–2.85) (104–193) (1.81–3.24) (−0.18–0.43)
China 0.686 29,177 1.79 39,079 2.05 0.15 11,289 1.44 16,111 1.74 0.20 17,887 2.18 22,968 2.41 0.10 1.39
(25,992–33,001) (1.6–2.02) (32,279–47,658) (1.7–2.5) (−0.05–0.38) (9494–12,803) (1.21–1.63) (12,076–20,192) (1.32–2.16) (−0.06–0.53) (15,433–21,440) (1.88–2.6) (17,457–30,160) (1.83–3.17) (−0.16–0.43)
Indonesia 0.66 5065 2.50 6672 2.66 0.06 1130 1.21 1700 1.44 0.19 3935 3.74 4972 3.83 0.02 2.67
(3360–6080) (1.69–2.96) (4626–8372) (1.88–3.3) (−0.15–0.33) (867–1364) (0.95–1.44) (1235–2308) (1.07–1.9) (−0.1–0.56) (2295–4901) (2.21–4.62) (3009–6548) (2.34–4.97) (−0.22–0.39)
Iran (Islamic Republic of) 0.67 1762 2.54 3198 3.63 0.43 491 1.42 956 2.15 0.51 1270 3.67 2242 5.11 0.39 2.38
(1242–1943) (1.81–2.8) (1999–3649) (2.31–4.12) (0.24–0.59) (373–557) (1.12–1.59) (634–1129) (1.46–2.52) (0.24–0.78) (871–1439) (2.54–4.15) (1310–2643) (3.08–5.96) (0.16–0.59)
Iraq 0.671 686 2.96 1282 4.03 0.36 179 1.63 367 2.39 0.47 507 4.34 915 5.71 0.32 2.39
(504–921) (2.21–3.94) (895–1779) (2.85–5.49) (0.03–0.78) (130–244) (1.2–2.2) (252–510) (1.7–3.24) (0.08–0.99) (352–718) (3.09–6.11) (597–1329) (3.85–8.04) (−0.05–0.79)
Philippines 0.623 2773 3.82 4015 4.30 0.12 637 1.87 984 2.22 0.18 2137 5.69 3031 6.31 0.11 2.85
(2397–3156) (3.35–4.35) (3102–5169) (3.34–5.5) (−0.12–0.42) (537–741) (1.6–2.16) (706–1299) (1.61–2.91) (−0.16–0.59) (1766–2533) (4.74–6.71) (2181–4159) (4.57–8.57) (−0.17–0.5)
Syrian Arab Republic 0.619 124 0.86 138 0.97 0.13 43 0.59 49 0.68 0.16 80 1.16 89 1.25 0.08 1.83
(88–153) (0.58–1.07) (89–190) (0.63–1.32) (−0.17–0.48) (31–56) (0.41–0.77) (32–70) (0.45–0.96) (−0.19–0.65) (53–104) (0.69–1.49) (52–124) (0.73–1.72) (−0.21–0.46)
Thailand 0.687 2261 2.87 2667 2.74 −0.04 599 1.60 796 1.74 0.09 1662 4.01 1871 3.64 −0.09 2.09
(1843–3372) (2.35–4.15) (1794–4452) (1.86–4.59) (−0.34–0.35) (477–793) (1.28–2.06) (543–1256) (1.21–2.74) (−0.26–0.6) (1312–2677) (3.18–6.28) (1215–3461) (2.34–6.83) (−0.39–0.33)
Turkmenistan 0.67 50 1.29 80 1.66 0.29 15 0.81 26 1.09 0.33 35 1.73 54 2.21 0.28 2.03
(45–55) (1.18–1.42) (63–103) (1.3–2.13) (0.01–0.67) (13–17) (0.71–0.93) (20–33) (0.85–1.41) (0.03–0.73) (31–40) (1.55–1.94) (42–71) (1.69–2.87) (−0.02–0.67)
Uzbekistan 0.631 123 0.66 247 0.93 0.41 38 0.44 73 0.61 0.38 86 0.85 174 1.22 0.44 2.01
(112–136) (0.61–0.72) (200–299) (0.77–1.12) (0.15–0.71) (32–43) (0.38–0.5) (56–92) (0.46–0.74) (0.09–0.72) (75–97) (0.76–0.95) (138–214) (0.98–1.48) (0.14–0.78)
Vietnam 0.617 5276 6.08 7789 7.25 0.19 1361 3.57 2146 4.35 0.22 3916 8.44 5643 10.04 0.19 2.31
(3244–6837) (4.04–7.73) (5009–10,487) (4.77–9.6) (−0.08–0.54) (810–1778) (2.33–4.46) (1348–2993) (2.86–5.88) (−0.08–0.58) (2177–5287) (4.94–11.19) (3281–7827) (5.93–13.81) (−0.1–0.59)
Low‐middle SDI
Bangladesh 0.483 1504 1.30 2322 1.54 0.18 375 0.70 551 0.76 0.10 1129 1.93 1772 2.29 0.19 3.00
(1125–2104) (1–1.74) (1587–3465) (1.06–2.25) (−0.09–0.53) (264–517) (0.49–0.94) (378–828) (0.52–1.13) (−0.18–0.46) (786–1704) (1.41–2.77) (1133–2841) (1.5–3.63) (−0.11–0.59)
Bhutan 0.455 10 1.69 14 2.07 0.22 2 0.89 4 1.11 0.24 7 2.61 11 3.12 0.19 2.82
(7–14) (1.23–2.34) (9–21) (1.43–2.94) (−0.05–0.55) (2–4) (0.56–1.28) (2–6) (0.69–1.68) (−0.06–0.6) (5–11) (1.75–3.73) (7–16) (2.04–4.74) (−0.1–0.58)
Cambodia 0.469 298 2.90 495 3.61 0.24 54 1.26 93 1.60 0.26 244 4.18 401 5.25 0.26 3.29
(185–393) (1.83–3.79) (305–676) (2.26–4.87) (−0.01–0.56) (40–73) (0.94–1.66) (66–123) (1.13–2.06) (−0.02–0.61) (141–331) (2.46–5.57) (226–560) (2.98–7.3) (−0.02–0.64)
Democratic People's Republic of Korea 0.558 682 2.41 763 2.39 −0.01 155 1.26 202 1.32 0.05 527 3.51 561 3.49 −0.01 2.64
(485–959) (1.76–3.35) (544–1072) (1.7–3.37) (−0.23–0.28) (101–241) (0.86–1.9) (131–305) (0.89–1.94) (−0.18–0.36) (352–791) (2.33–5.22) (375–845) (2.28–5.39) (−0.26–0.36)
India 0.566 16,357 1.55 23,823 1.81 0.16 4240 0.86 6276 1.00 0.16 12,118 2.27 17,547 2.64 0.16 2.64
(13,758–18,296) (1.31–1.74) (19,467–28,644) (1.48–2.17) (−0.03–0.4) (3620–4793) (0.73–0.97) (5050–7557) (0.8–1.2) (−0.08–0.44) (9506–13,963) (1.78–2.6) (13,225–22,175) (1.99–3.32) (−0.08–0.46)
Kyrgyzstan 0.596 61 1.39 83 1.51 0.09 11 0.57 17 0.65 0.15 50 2.10 67 2.25 0.07 3.46
(54–68) (1.25–1.55) (68–101) (1.26–1.82) (−0.11–0.32) (10–13) (0.49–0.65) (13–21) (0.53–0.8) (−0.07–0.43) (43–57) (1.84–2.4) (53–83) (1.81–2.77) (−0.14–0.33)
Lao People's Democratic Republic 0.49 96 2.35 140 2.61 0.11 20 1.05 30 1.20 0.14 76 3.59 110 3.96 0.10 3.28
(58–131) (1.45–3.14) (86–196) (1.62–3.55) (−0.11–0.39) (13–27) (0.73–1.41) (21–41) (0.86–1.59) (−0.12–0.52) (40–108) (1.93–4.96) (59–160) (2.15–5.64) (−0.14–0.42)
Maldives 0.562 7 2.86 13 3.20 0.12 4 2.97 8 3.52 0.18 3 2.71 5 2.88 0.06 0.82
(6–8) (2.5–3.27) (10–16) (2.59–3.94) (−0.09–0.37) (3–4) (2.48–3.63) (6–11) (2.77–4.48) (−0.09–0.51) (3–4) (2.19–3.23) (4–6) (2.2–3.67) (−0.17–0.35)
Mongolia 0.606 26 1.45 41 1.48 0.02 10 1.01 15 1.09 0.08 17 1.79 26 1.76 −0.02 1.62
(15–34) (0.67–1.88) (22–56) (0.71–2.03) (−0.21–0.37) (5–13) (0.44–1.35) (7–22) (0.51–1.52) (−0.23–0.46) (9–22) (0.73–2.38) (13–37) (0.79–2.5) (−0.27–0.36)
Myanmar 0.521 1045 2.48 1437 2.77 0.12 212 1.15 312 1.37 0.19 833 3.62 1125 3.94 0.09 2.88
(681–1366) (1.66–3.18) (996–1902) (1.96–3.64) (−0.14–0.42) (149–284) (0.83–1.51) (225–412) (1–1.79) (−0.11–0.59) (482–1123) (2.15–4.79) (709–1528) (2.51–5.3) (−0.19–0.45)
Palestine 0.588 52 2.31 110 3.43 0.49 10 0.94 19 1.23 0.32 42 3.55 91 5.57 0.57 4.51
(44–61) (1.93–2.68) (77–139) (2.41–4.26) (0.12–0.86) (8–12) (0.77–1.12) (15–24) (0.96–1.54) (0.02–0.68) (34–51) (2.88–4.23) (59–118) (3.65–7) (0.1–1.04)
Tajikistan 0.539 19 0.44 28 0.48 0.09 7 0.33 10 0.37 0.11 12 0.54 18 0.58 0.07 1.56
(15–22) (0.32–0.52) (22–35) (0.34–0.6) (−0.14–0.38) (5–8) (0.22–0.42) (7–13) (0.24–0.48) (−0.16–0.45) (9–14) (0.37–0.65) (14–23) (0.4–0.74) (−0.18–0.39)
Timor‐Leste 0.514 13 1.82 21 2.38 0.31 2 0.72 4 1.00 0.39 10 2.96 17 3.80 0.28 3.78
(8–17) (1.13–2.46) (13–29) (1.49–3.27) (0.02–0.7) (2–4) (0.47–1.11) (3–6) (0.65–1.43) (0.08–0.87) (6–14) (1.75–4.08) (10–24) (2.19–5.4) (−0.03–0.7)
Low SDI
Afghanistan 0.343 280 2.00 439 2.23 0.11 45 0.73 75 0.83 0.14 235 3.21 364 3.60 0.12 4.33
(138–460) (1.1–3.11) (221–726) (1.26–3.44) (−0.14–0.41) (27–76) (0.43–1.19) (47–120) (0.53–1.29) (−0.12–0.49) (94–411) (1.44–5.36) (154–635) (1.72–5.87) (−0.15–0.44)
Nepal 0.422 299 1.41 490 1.87 0.33 59 0.63 103 0.90 0.43 240 2.13 387 2.70 0.26 2.99
(225–406) (1.1–1.89) (341–681) (1.34–2.55) (0.02–0.69) (38–83) (0.41–0.86) (63–150) (0.56–1.32) (0.06–0.84) (173–345) (1.59–2.96) (264–566) (1.89–3.85) (−0.05–0.65)
Pakistan 0.449 3152 2.57 4885 2.96 0.15 840 1.48 1267 1.67 0.13 2312 3.71 3618 4.29 0.15 2.56
(2465–3900) (2.08–3.11) (3650–6521) (2.3–3.81) (−0.13–0.52) (642–1069) (1.15–1.86) (911–1766) (1.21–2.29) (−0.21–0.6) (1677–3034) (2.79–4.73) (2410–5381) (2.95–6.08) (−0.2–0.69)
Yemen 0.412 213 1.59 356 1.86 0.17 45 0.69 73 0.80 0.16 168 2.49 283 2.91 0.17 3.65
(138–317) (1.1–2.26) (228–517) (1.26–2.66) (−0.09–0.49) (29–69) (0.46–1.05) (46–114) (0.51–1.24) (−0.13–0.53) (103–261) (1.62–3.69) (167–434) (1.82–4.32) (−0.12–0.54)

3.1.5. National comparison

Among Asian countries, 11 countries experienced a decreasing trend in the ThC morbidity rate between 2010 and 2019; the greatest decrease was detected in the Republic of Korea (decrease in ASIR = −0.54 (95% CI: −0.65 to −0.01)), and the greatest increase was detected in Armenia (increase in ASIR = 0.82 (95% CI: 0.42–1.25)) (Figure 2).

FIGURE 2.

FIGURE 2

The relative change (%) in age‐standardized incidence rate (ASIR), age‐standardized death rate (ASMR), age‐standardized DALYs rate (DALYs ASR), and age‐standardized prevalence rate (ASPR) of ThC cancer in Asian countries from 2010 to 2019.

In 2019, the highest ASIR (per 100,000) of THC was reported in Lebanon (7.95), Vietnam (7.25), the Republic of Korea (6.77), Saudi Arabia (5.98), Brunei Darussalam (5.09), and Taiwan (5.01). The lowest ASIR of ThC was reported in Tajikistan (0.48), Uzbekistan (0.93), and Syrian Arab Republic (0.97).

In 2019, the highest ASIR (per 100,000) of ThC in men was reported in Lebanon (4.91), Vietnam (4.35), the United Arab Emirates (3.53), Maldives (3.52), the Republic of Korea (3.37), Taiwan (3.35), Saudi Arabia (3.23), and Israel (3.21). The lowest ASIR of ThC was reported in Tajikistan (0.37), Uzbekistan (0.61), Kyrgyzstan (0.65), Syrian Arab Republic (0.68), Bangladesh (0.76), Yemen (0.80), Afghanistan (0.83), Nepal (0.90), and Azerbaijan (0.98).

In 2019, the highest ASIR (per 100,000) of ThC in women was reported in Lebanon (10.67), Republic of Korea (10.25), Saudi Arabia (10.20), Vietnam (10.04), and Brunei Darussalam (8.00). The lowest ASIR of ThC was reported in Tajikistan (0.58), Uzbekistan (1.22), the Syrian Arab Republic (1.25), and Mongolia (1.76). Results in detail are presented in Table 3.

3.1.6. Male/female ratio

In 2019, the ASIR of ThC in Maldives was reported to be higher in men than in women. In other countries, the incidence of THC in women was higher than in men. The highest ratio was reported in Palestine (4.51‐fold) and the lowest ratio was recorded in Maldives (0.82‐fold). Similarly, in 2010, this ratio in Maldives was higher in men than in women (Figure 3).

FIGURE 3.

FIGURE 3

The female/male ratio in age‐standardized incidence rate (ASIR), age‐standardized death rate (ASMR), age‐standardized DALYs rate (DALYs ASR), and age‐standardized prevalence rate (ASPR) of ThC cancer in Asian countries based on SDI, 2019.

3.2. Death rates of THC in Asia

3.2.1. Compared with global data and continents

In Asia, the number of ThC deaths increased from 21,405 (95% CI: 18,846–22,632) in 2010 to 26,982 (95% CI: 23,978–29,391) in 2019, which is over a 1.26‐fold increase. In 2019, more than 59% (26,982/45,576) of ThC deaths happened in Asia countries. During this period, the ASDR of ThC had a 6% change, decreasing from 0.63 (95% CI: 0.55–0.66) per 100,000 in 2010 to 0.59 (95% CI: 0.52–0.64) per 100,000 in 2019. Also, at the same time, this rate globally decreased by 5%, in America by 1%, and Europe by 9%. This rate was stable in Africa at this time (Figure 4 and Table 1).

FIGURE 4.

FIGURE 4

Temporal trend of incidence, prevalence, death, and DALYs age standard rates (per 100,000 population) of thyroid cancer in Asia compared with global data and other continents from 2010 to 2019.

In Asian men, the number of ThC deaths increased from 8867 (95% CI: 7483–9442) in 2010 to 11,465 (95% CI: 9819–12,908) in 2019, which is over a 1.29‐fold increase. In 2019, 42.49% (11,465/26,982) of Asian ThC deaths occurred in Asian men, which included 61.52% (11,465/18,635) of global male ThC death cases. During this period, the ASDR of ThC had a 2% change, decreasing from 0.55 (95% CI: 0.46–0.59) per 100,000 in 2010 to 0.54 (95% CI: 0.46–0.60) per 100,000 in 2019, while at the same time, this rate globally decreased by 1% and in Europe by 6%. This rate increased in America by 3% and in Africa by 4% (Table 4).

TABLE 4.

The comparing incidence, death, prevalence, and burden rates of thyroid cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019 (males).

Location Incidence Death Prevalence DALY
2010 2019 % change 2010–2019 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000
Global 59,341 1.81 76,014 1.90 0.05 14,744 0.51 18,635 0.51 −0.01 437,780 12.77 562,741 13.70 0.07 420,674 13.14 509,842 12.93 −0.02
(52,845–62,189) (1.61–1.9) (68,232–82,923) (1.71–2.07) (−0.04–0.14) (13,094–15,502) (0.45–0.54) (16,822–20,242) (0.46–0.55) (−0.09–0.07) (388,455–457,734) (11.34–13.35) (502,727–615,420) (12.25–14.97) (−0.03–0.17) (375,586–445,036) (11.74–13.89) (461,647–553,336) (11.7–14.02) (−0.1–0.07)
Continents
Africa 2194 0.73 3436 0.86 0.19 936 0.40 1261 0.41 0.04 13,084 3.56 22,404 4.76 0.34 30,806 10.44 41,146 10.74 0.03
(1898–2481) (0.63–0.83) (2928–4020) (0.75–1.01) (0.02–0.34) (801–1097) (0.34–0.47) (1092–1497) (0.36–0.49) (−0.08–0.16) (11,304–14,693) (3.12–4.02) (18,829–26,306) (3.99–5.63) (0.15–0.52) (26,040–36,106) (8.93–12.25) (34,988–48,795) (9.27–12.77) (−0.1–0.15)
America 13,672 2.90 17,131 2.99 0.03 2186 0.49 2872 0.50 0.03 108,873 22.81 135,052 23.56 0.03 60,584 13.05 75,968 13.25 0.02
(13,083–14,218) (2.76–3.01) (14,652–20,134) (2.56–3.51) (−0.11–0.2) (2014–2270) (0.45–0.51) (2629–3083) (0.46–0.54) (−0.03–0.09) (10,4295–11,3692) (21.79–23.78) (11,4872–15,9952) (20.07–27.88) (−0.12–0.21) (57,227–64,251) (12.29–13.84) (69,938–82,870) (12.22–14.45) (−0.04–0.09)
Asia 29,253 1.50 40,021 1.65 0.10 8867 0.55 11,465 0.54 −0.02 205,125 9.67 285,342 11.18 0.16 256,437 13.54 316,821 13.30 −0.02
(24,129–31,446) (1.23–1.61) (33,634–45,216) (1.39–1.86) (−0.05–0.24) (7483–9442) (0.46–0.59) (9819–12,908) (0.46–0.6) (−0.14–0.09) (169,386–221,225) (7.98–10.41) (239,841–324,527) (9.42–12.69) (0–0.32) (217,071–275,000) (11.49–14.46) (272,355–354,527) (11.41–14.88) (−0.14–0.1)
Europe 14,139 2.66 15,321 2.67 0.00 2733 0.49 3009 0.47 −0.06 110,088 20.94 119,171 21.24 0.01 72,276 13.26 75,193 12.37 −0.07
(12,523–14,790) (2.37–2.78) (13,383–17,349) (2.33–3.01) (−0.11–0.14) (2554–2836) (0.46–0.51) (2727–3250) (0.42–0.5) (−0.11–0) (96,454–115,495) (18.39–21.93) (103,553–136,208) (18.49–24.17) (−0.11–0.16) (67,619–76,240) (12.41–13.99) (68,124–83,253) (11.23–13.7) (−0.13–0.01)
Asian GBD regions
Central Asia 242 0.77 375 0.96 0.24 86 0.34 115 0.38 0.11 1596 4.40 2627 5.88 0.34 2737 9.09 3629 9.73 0.07
(224–263) (0.72–0.83) (323–424) (0.83–1.08) (0.09–0.4) (81–91) (0.32–0.36) (100–129) (0.33–0.42) (−0.02–0.23) (1463–1767) (4.03–4.87) (2243–3002) (5.05–6.7) (0.16–0.54) (2579–2933) (8.55–9.66) (3132–4089) (8.44–10.91) (−0.06–0.2)
East Asia 11,895 1.47 16,891 1.75 0.20 3426 0.53 4355 0.52 −0.03 85,588 9.64 124,587 12.41 0.29 92,052 11.90 111,067 11.64 −0.02
(10,040–13,394) (1.23–1.65) (12,854–20,999) (1.34–2.17) (−0.06–0.51) (2735–3824) (0.42–0.59) (3324–5373) (0.4–0.63) (−0.22–0.19) (73,127–97,155) (8.28–10.92) (95,008–155,402) (9.55–15.43) (0.01–0.64) (75,140–103,306) (9.59–13.25) (85,215–137,095) (9–14.22) (−0.22–0.2)
High‐income Asia Pacific 5261 3.94 4283 2.75 −0.30 889 0.58 899 0.44 −0.24 42,007 32.22 32,613 22.20 −0.31 21,442 14.94 18,056 10.26 −0.31
(3441–5833) (2.52–4.39) (3405–5180) (2.21–3.3) (−0.43 to −0.03) (632–942) (0.4–0.62) (713–984) (0.35–0.48) (−0.3 to −0.1) (26,849–47,081) (20.24–36.21) (25,657–39,972) (17.78–26.9) (−0.45 to −0.02) (14,309–23,288) (9.71–16.28) (14,954–20,085) (8.49–11.51) (−0.38 to −0.1)
North Africa and Middle East 3134 1.47 5667 1.97 0.34 659 0.41 970 0.44 0.09 24,518 10.61 45,985 15.07 0.42 21,146 10.96 31,063 12.04 0.10
(2806–3484) (1.32–1.63) (4601–6669) (1.63–2.31) (0.16–0.51) (595–761) (0.37–0.49) (820–1149) (0.38–0.54) (−0.04–0.2) (21,504–27,385) (9.44–11.83) (36,968–54,279) (12.2–17.8) (0.22–0.61) (18,986–23,535) (9.89–12.32) (25,897–36,269) (10.13–14.02) (−0.04–0.21)
South Asia 5516 0.90 8200 1.04 0.16 2637 0.51 3537 0.52 0.01 30,649 4.30 48,976 5.62 0.31 85,038 13.85 108,134 13.85 0.00
(4812–6147) (0.78–1) (6808–9674) (0.86–1.22) (−0.07–0.39) (2289–2973) (0.44–0.57) (2996–4155) (0.44–0.6) (−0.17–0.21) (26,913–34,129) (3.77–4.77) (40,189–58,798) (4.61–6.72) (0.05–0.58) (74,075–95,358) (12.02–15.5) (91,579–126,638) (11.71–16.25) (−0.18–0.19)
Southeast Asia 4400 1.72 6715 2.07 0.20 1469 0.72 2012 0.75 0.04 29,788 10.32 47,234 13.36 0.30 44,013 18.32 58,747 18.99 0.04
(3678–4926) (1.47–1.91) (5439–8040) (1.7–2.46) (0–0.42) (1261–1606) (0.64–0.79) (1698–2366) (0.63–0.88) (−0.11–0.19) (24,526–34,014) (8.53–11.69) (37,607–57,180) (10.7–16.09) (0.06–0.55) (36,771–48,742) (15.58–20.1) (48,885–69,102) (15.96–22.24) (−0.11–0.2)

In Asian women, the number of ThC deaths increased from 12,538 (95% CI: 10,640–13,594) in 2010 to 15,517 (95% CI: 13,103–17,318) in 2019, which is over a 1.24‐fold increase. In 2019, approximately 57.51% (15,517/26,982) of Asian ThC deaths occurred in Asian women, which included 42.75% (11,517/26,941) of global female ThC death cases. During this period, the ASIR of ThC had 8% changes, decreasing from 0.69 (95% CI: 0.59–0.75) per 100,000 in 2010 to 0.64 (95% CI: 0.54–0.71) per 100,000 in 2019. At the same time, this rate globally decreased by 6%, in Europe by 11%, and in America and Africa by 3% (Table 5).

TABLE 5.

The comparing incidence, death, prevalence, and burden rates of thyroid cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019 (females).

Location Incidence Death Prevalence DALY
2010 2019 % change 2010–2019 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000
Global 131,855 3.76 157,833 3.74 −0.01 22,525 0.66 26,941 0.62 −0.06 1,058,584 29.97 1,269,019 30.17 0.01 625,211 18.01 721,999 16.94 −0.06
(116,108–137,983) (3.32–3.93) (140,395–173,068) (3.32–4.1) (−0.08–0.08) (19,946–23,888) (0.59–0.7) (23,718–29,329) (0.55–0.68) (−0.12 to −0.01) (925,303–1,106,520) (26.27–31.31) (1,123,383–1,393,452) (26.71–33.15) (−0.07–0.1) (544,936–672,424) (15.73–19.36) (627,829–792,461) (14.72–18.62) (−0.13–0.01)
Continents
Africa 7289 2.12 10,897 2.38 0.12 1802 0.72 2316 0.70 −0.03 54,674 14.19 85,181 16.95 0.19 61,288 19.52 78,174 18.83 −0.04
(5612–8352) (1.72–2.41) (8401–13,293) (1.91–2.83) (0–0.29) (1479–2047) (0.59–0.81) (1878–2748) (0.57–0.82) (−0.11–0.08) (41,671–63,223) (11.23–16.2) (65,133–104,159) (13.4–20.38) (0.04–0.38) (49,174–70,178) (15.84–22.19) (62,057–94,510) (15.07–22.52) (−0.14–0.09)
America 24,014 4.59 28,094 4.44 −0.03 3584 0.65 4415 0.63 −0.03 195,286 37.67 227,004 36.50 −0.03 90,138 17.06 107,238 16.32 −0.04
(23,117–24,741) (4.43–4.73) (24,531–32,170) (3.88–5.1) (−0.16–0.11) (3291–3752) (0.6–0.68) (3969–4801) (0.57–0.68) (−0.09–0.03) (188,596–200,948) (36.4–38.75) (197,359–262,528) (31.72–42.27) (−0.16–0.12) (83,896–95,527) (15.89–18.08) (96,816–118,462) (14.72–18.11) (−0.11–0.03)
Asia 69,379 3.38 86,988 3.49 0.03 12,538 0.69 15,517 0.64 −0.08 554,856 26.34 696,999 27.77 0.05 368,534 18.64 434,163 17.48 −0.06
(56,407–74,309) (2.77–3.62) (73,241–97,296) (2.93–3.9) (−0.07–0.15) (10,640–13,594) (0.59–0.75) (13,103–17,318) (0.54–0.71) (−0.16–0.01) (447,358–595,190) (21.31–28.2) (582,544–783,841) (23.15–31.19) (−0.05–0.19) (304,476–400,999) (15.61–20.23) (362,794–486,695) (14.65–19.64) (−0.15–0.03)
Europe 31,028 5.16 31,688 4.92 −0.05 4574 0.56 4661 0.50 −0.11 252,625 43.70 258,523 41.99 −0.04 104,553 15.26 101,636 13.44 −0.12
(29,881–32,031) (4.98–5.33) (28,480–35,551) (4.42–5.55) (−0.14–0.07) (4196–4773) (0.53–0.59) (4154–5028) (0.45–0.54) (−0.16 to −0.05) (243,625–261,116) (42.18–45.23) (232,371–290,635) (37.58–47.26) (−0.13–0.08) (97,980–111,133) (14.26–16.34) (91,856–111,544) (12.15–14.87) (−0.17 to −0.05)
Asian GBD regions
Central Asia 733 1.94 1092 2.34 0.20 158 0.48 193 0.49 0.02 5692 14.51 8827 18.14 0.25 4524 12.74 5603 12.79 0.00
(685–786) (1.82–2.08) (956–1242) (2.05–2.64) (0.06–0.36) (148–166) (0.46–0.51) (173–215) (0.44–0.55) (−0.08–0.12) (5292–6147) (13.5–15.65) (7693–101,23) (15.8–20.72) (0.09–0.43) (4247–4804) (11.98–13.5) (4955–6333) (11.38–14.38) (−0.1–0.12)
East Asia 19,406 2.28 24,688 2.50 0.09 2788 0.36 3266 0.31 −0.14 160,700 18.61 206,107 20.97 0.13 77,637 9.54 86,270 8.40 −0.12
(16,919–22,887) (2–2.68) (19,158–31,886) (1.94–3.23) (−0.15–0.39) (2434–3291) (0.32–0.43) (2627–3999) (0.25–0.38) (−0.31–0.06) (139,603–190,957) (16.21–21.97) (159,523–267,428) (16.27–27.17) (−0.13–0.44) (69,274–93,254) (8.5–11.42) (70,536–105,550) (6.89–10.26) (−0.28–0.07)
High‐income Asia Pacific 14,795 11.01 11,377 7.20 −0.35 1675 0.73 1855 0.59 −0.20 124,506 96.74 90,936 62.48 −0.35 34,765 20.56 30,964 14.39 −0.30
(9830–16,456) (6.59–12.46) (9300–13,534) (5.84–8.59) (−0.47–0) (1296–1866) (0.57–0.81) (1366–2114) (0.47–0.66) (−0.25 to −0.06) (80,606–139,206) (56.95–109.69) (74,785–108,630) (50.5–74.44) (−0.47–0) (25,512–39,203) (13.76–23.72) (25,262–35,199) (11.97–16.61) (−0.37 to −0.07)
North Africa and Middle East 8739 4.23 13,586 5.06 0.20 1047 0.68 1319 0.64 ‐0.06 73,939 34.35 117,063 42.36 0.23 33,783 18.42 43,117 17.87 −0.03
(6682–9842) (3.4–4.73) (10,441–15,925) (4.01–5.88) (0.07–0.35) (931–1239) (0.61–0.86) (1133–1589) (0.56–0.8) (−0.14–0.04) (55,144–83,752) (26.59–38.72) (87,911–137,864) (32.74–49.32) (0.1–0.39) (28,203–38,291) (16.07–21.06) (35,094–50,876) (14.91–21.01) (−0.12–0.08)
South Asia 15,806 2.36 23,334 2.77 0.17 4248 0.79 5658 0.78 −0.01 117,305 16.22 177,491 20.16 0.24 146,730 23.20 183,441 22.81 −0.02
(12,602–17,797) (1.91–2.65) (18,491–27,846) (2.2–3.32) (−0.02–0.42) (3572–4813) (0.65–0.91) (4532–6743) (0.63–0.94) (−0.18–0.16) (91,885–132,495) (12.76–18.29) (139,963–213,055) (15.89–24.2) (0.04–0.51) (119,881–165,914) (19.21–26.18) (147,052–217,443) (18.27–27.02) (−0.18–0.16)
Southeast Asia 13,939 4.80 18,866 5.27 0.10 3155 1.33 3850 1.22 −0.08 106,624 34.69 147,665 39.94 0.15 88,689 33.43 105,556 30.87 −0.08
(10,566–15,808) (3.69–5.4) (14,094–22,235) (3.96–6.19) (−0.05–0.28) (2494–3524) (1.08–1.48) (3097–4395) (0.99–1.39) (−0.18–0.04) (79,825–122,234) (26.26–39.68) (109,364–175,581) (29.61–47.51) (−0.01–0.36) (65,994–100,571) (25.43–37.65) (80,215–122,086) (23.84–35.46) (−0.19–0.06)

3.2.2. Age distribution

In 2019, age‐specific death cases of ThC were peaking at 85 years and higher in both males and females. In all age groups, death cases of ThC in females were higher than in males, except in ages 75 to 79 years and 80 to 84 years, which was higher in males. In the 0 to 14 years group, males and females almost had the same death rates (Figure 5). In 2019, 12,399 deaths due to ThC in people aged ≥70 years were diagnosed in Asia, accounting for 45.95% of ThC deaths in all ages. This rate was 44.25% in men and 47.21% in women. Meanwhile, in the world, 22,298 deaths due to ThC were diagnosed in people ≥70 years, which includes 17.44% of ThC deaths in all ages. This rate was 18.65% in men and 16.85% in women. Overall, 55.61% of ThC deaths were recorded in the elderly aged ≥70 years in Asia (Table 2).

FIGURE 5.

FIGURE 5

Age‐specific death cases of ThC cancer among genders in Asia, 2019.

3.2.3. Within Asian regions

In 2019, the highest ASDR of ThC was observed in Southeast Asia regions (1.02 (95% CI: 0.88–1.15)), with a 4% decrease compared with 2010. Also in this period, East Asia and high‐income Asia Pacific had a decreasing trend of 8% and 22%, respectively. However, an increasing trend of 5% was observed in Central Asia. No changes in ASDR of ThC occurred in South Asia and North Africa and the Middle East from 2010 to 2019 (Figure 6 and Table 1).

FIGURE 6.

FIGURE 6

Temporal trend of incidence, prevalence, death, and DALYs age standard rates (per 100,000 population) of stomach cancer in Asian regions from 1990 to 2019.

In men, the highest ASDR of ThC was observed in Southeast Asia countries (0.75 (95% CI: 0.63–0.88)), with a 4% increase compared with 2010. Also in this period, Central Asia, South Asia, and North Africa and the Middle East had an increasing trend of 11%, 1%, and 9%, respectively. However, a decreasing trend was observed in East Asia (3%) and high‐income Asia Pacific countries (24%).

In women, the highest ASDR of ThC was observed in Southeast Asia countries (1.22 (95% CI: 0.99–1.39)), with an 8% decrease compared with 2010. Also, in this period, all Asian regions had a decreasing trend of 1% (South Asia) to 20% (high‐income Asia Pacific) except Central Asia, which had an increasing trend of 2% (Table 5).

3.2.4. Based on SDI

In 2019, among high SDI Asian countries, Brunei Darussalam (1.25) and the United Arab Emirates (0.82) have the highest ASDR of ThC, and Singapore (0.44) has the lowest rate. In this classification, between 2010 and 2019, all countries recorded a downward trend between 1% (Taiwan (Province of China)) to 43% (Republic of Korea). Among high‐middle SDI Asian countries, Malaysia (0.93) and Bahrain (0.73) have the highest ASDR of ThC and Oman (0.49) has the lowest rate. In this classification, between 2010 and 2019, all countries recorded a downward trend between 3% (Sri Lanka) to 26% (Bahrain) except Georgia, which had an increasing trend of 20%, and Lebanon, which had no changes. Among middle SDI Asian countries, the Philippines and Vietnam have the highest ASDR of ThC (1.34), and the Syrian Arab Republic (0.18) has the lowest rate. In this group, five countries reported a downward trend and seven countries reported an upward trend; the most upward trend was observed by Armenia (65%) and the most downward trend was observed in Thailand (17%) from 2010 to 2019. Among low‐middle SDI Asian countries, Cambodia (1.33) has the highest ASDR of ThC and Tajikistan (0.24) has the lowest rate. In this group, seven countries reported a downward trend and six countries reported an upward trend; Palestine experienced the most upward trend (15%) and Mongolia reported the most downward trend (11%) from 2010 to 2019. Among low SDI Asian countries, Pakistan (1.08) has the highest ASDR of ThC and Yemen (0.54) has the lowest rate. In this group, two countries experienced a downward trend and two countries reported an upward trend from 2010 to 2019. More details are presented in Table 6.

TABLE 6.

The death distribution of thyroid cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019, by geographical region and SDI.

Location SDI 2019 Both Male Female F/M Ratio
2010 2019 % change 1990–2010 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000
High SDI
Brunei Darussalam 0.823 2 1.31 3 1.25 −0.04 1 0.87 1 0.90 0.04 1 1.65 2 1.53 −0.08 1.69
(2–2) (1.05–1.48) (2–3) (1.01–1.45) (−0.18–0.11) (1–1) (0.7–1.01) (1–1) (0.71–1.12) (−0.16–0.27) (1–2) (1.23–1.94) (2–2) (1.17–1.83) (−0.23–0.11)
Cyprus 0.841 8 0.61 9 0.49 −0.20 3 0.56 4 0.43 −0.23 5 0.64 5 0.52 −0.19 1.20
(6–9) (0.49–0.68) (7–11) (0.4–0.57) (−0.31 to −0.06) (3–4) (0.45–0.64) (3–5) (0.35–0.52) (−0.37 to −0.06) (4–6) (0.48–0.75) (4–7) (0.42–0.63) (−0.33–0.01)
Israel 0.803 76 0.84 86 0.73 −0.14 29 0.73 34 0.64 −0.12 47 0.93 53 0.79 −0.15 1.23
(65–83) (0.72–0.91) (74–97) (0.62–0.81) (−0.22 to −0.05) (22–32) (0.56–0.81) (27–39) (0.53–0.74) (−0.24–0.02) (41–52) (0.81–1.02) (44–61) (0.66–0.91) (−0.26 to −0.03)
Japan 0.87 1827 0.55 2139 0.49 −0.10 619 0.47 694 0.41 −0.12 1208 0.59 1445 0.54 −0.09 1.30
(1433–2004) (0.45–0.59) (1611–2403) (0.39–0.54) (−0.14 to −0.06) (509–655) (0.39–0.5) (562–767) (0.35–0.46) (−0.17 to −0.05) (911–1358) (0.48–0.65) (1041–1652) (0.43–0.6) (−0.12 to −0.04)
Kuwait 0.851 8 0.62 12 0.56 −0.10 4 0.44 7 0.51 0.17 5 0.94 5 0.64 −0.32 1.25
(7–9) (0.55–0.69) (10–14) (0.45–0.67) (−0.24–0.07) (3–4) (0.37–0.5) (5–8) (0.39–0.65) (−0.09–0.51) (4–5) (0.8–1.07) (4–7) (0.5–0.81) (−0.45 to −0.16)
Qatar 0.83 2 0.75 3 0.58 −0.23 1 0.49 2 0.42 −0.13 1 1.44 1 1.09 −0.25 2.57
(2–3) (0.58–0.89) (2–5) (0.44–0.75) (−0.4–0) (1–2) (0.33–0.63) (1–3) (0.29–0.59) (−0.39–0.2) (1–1) (0.86–1.81) (1–2) (0.79–1.48) (−0.46–0.11)
Republic of Korea 0.878 710 1.19 580 0.68 −0.43 261 0.98 192 0.52 −0.47 449 1.30 388 0.78 −0.40 1.49
(323–785) (0.57–1.32) (426–679) (0.5–0.79) (−0.51 to −0.12) (112–291) (0.47–1.08) (143–230) (0.39–0.61) (−0.56 to −0.15) (208–509) (0.6–1.48) (272–474) (0.54–0.95) (−0.5 to −0.05)
Saudi Arabia 0.805 86 0.74 121 0.66 ‐0.12 38 0.57 61 0.56 −0.03 48 0.97 60 0.80 −0.17 1.43
(73–98) (0.64–0.83) (93–154) (0.52–0.81) (−0.27–0.06) (32–45) (0.49–0.66) (46–79) (0.43–0.69) (−0.22–0.2) (39–57) (0.8–1.12) (44–81) (0.61–1.06) (−0.36–0.06)
Singapore 0.861 25 0.53 33 0.44 −0.18 9 0.40 12 0.36 −0.10 16 0.63 20 0.50 −0.21 1.39
(22–27) (0.48–0.59) (28–37) (0.37–0.5) (−0.26 to −0.08) (8–10) (0.36–0.46) (10–15) (0.3–0.44) (−0.24–0.06) (14–18) (0.55–0.71) (17–24) (0.42–0.58) (−0.31 to −0.08)
Taiwan (Province of China) 0.868 166 0.56 217 0.55 −0.01 68 0.46 87 0.48 0.04 98 0.65 130 0.61 −0.06 1.26
(147–178) (0.49–0.6) (166–279) (0.42–0.71) (−0.22–0.27) (59–74) (0.4–0.51) (64–114) (0.36–0.63) (−0.2–0.35) (86–107) (0.56–0.71) (98–167) (0.46–0.78) (−0.26–0.21)
United Arab Emirates 0.88 19 1.00 42 0.82 −0.18 15 0.85 35 0.87 0.02 4 1.29 7 0.67 −0.48 0.77
(11–27) (0.49–1.47) (22–66) (0.41–1.23) (−0.37–0.04) (8–22) (0.39–1.27) (16–55) (0.4–1.38) (−0.22–0.32) (2–6) (0.54–2.16) (4–12) (0.33–1.11) (−0.6 to −0.26)
High‐middle SDI
Bahrain 0.751 3 0.99 5 0.73 ‐0.26 1 0.51 2 0.40 −0.21 2 1.47 3 1.10 −0.25 2.73
(2–4) (0.58–1.18) (3–6) (0.49–0.93) (−0.42 to −0.06) (1–1) (0.39–0.62) (1–2) (0.29–0.53) (−0.43–0.05) (1–3) (0.72–1.82) (2–4) (0.61–1.44) (−0.42 to −0.01)
Georgia 0.702 27 0.46 32 0.55 0.20 9 0.36 11 0.48 0.33 19 0.54 21 0.61 0.13 1.29
(24–30) (0.41–0.51) (25–38) (0.43–0.66) (−0.03–0.42) (6–10) (0.27–0.41) (6–14) (0.27–0.58) (−0.05–0.66) (16–21) (0.47–0.61) (17–25) (0.49–0.73) (−0.09–0.37)
Jordan 0.731 19 0.63 34 0.58 −0.08 7 0.45 14 0.41 −0.07 12 0.84 21 0.76 −0.10 1.83
(17–23) (0.54–0.75) (28–43) (0.47–0.73) (−0.26–0.11) (6–9) (0.37–0.55) (10–19) (0.31–0.56) (−0.3–0.2) (10–15) (0.68–1.05) (15–28) (0.57–1.02) (−0.31–0.15)
Kazakhstan 0.723 90 0.63 99 0.58 −0.08 29 0.49 32 0.45 −0.08 60 0.71 66 0.66 −0.07 1.47
(84–97) (0.59–0.68) (83–116) (0.49–0.68) (−0.21–0.07) (27–35) (0.44–0.6) (26–42) (0.37–0.59) (−0.24–0.13) (55–66) (0.66–0.77) (56–77) (0.56–0.77) (−0.21–0.09)
Lebanon 0.708 28 0.67 35 0.67 0.00 13 0.64 17 0.70 0.10 15 0.70 18 0.64 −0.08 0.91
(23–36) (0.55–0.86) (28–46) (0.52–0.88) (−0.16–0.17) (10–17) (0.5–0.83) (12–22) (0.51–0.93) (−0.12–0.33) (12–20) (0.54–0.94) (14–26) (0.48–0.9) (−0.25–0.12)
Malaysia 0.737 171 0.98 234 0.93 −0.06 56 0.61 87 0.67 0.10 115 1.33 147 1.18 −0.11 1.75
(152–202) (0.86–1.17) (180–304) (0.71–1.19) (−0.26–0.17) (47–66) (0.51–0.72) (63–115) (0.48–0.88) (−0.16–0.42) (99–140) (1.12–1.62) (111–198) (0.89–1.58) (−0.31–0.13)
Oman 0.783 6 0.58 7 0.49 −0.15 3 0.45 3 0.40 −0.10 3 0.74 4 0.60 −0.18 1.51
(5–7) (0.49–0.64) (6–9) (0.41–0.57) (−0.27 to −0.01) (2–3) (0.38–0.52) (2–4) (0.31–0.5) (−0.3–0.12) (3–4) (0.58–0.87) (3–5) (0.47–0.75) (−0.34–0.01)
Sri Lanka 0.69 121 0.67 160 0.65 −0.03 44 0.54 57 0.53 −0.03 77 0.77 103 0.74 −0.03 1.41
(109–146) (0.6–0.82) (117–215) (0.48–0.86) (−0.28–0.26) (39–52) (0.47–0.64) (39–79) (0.36–0.72) (−0.32–0.3) (67–97) (0.67–0.99) (73–143) (0.54–1.03) (−0.29–0.28)
Turkey 0.748 399 0.61 455 0.53 −0.13 157 0.50 193 0.48 −0.05 242 0.69 261 0.57 −0.17 1.20
(346–478) (0.53–0.74) (353–635) (0.41–0.75) (−0.32–0.1) (133–207) (0.42–0.68) (145–293) (0.36–0.73) (−0.29–0.24) (203–289) (0.58–0.83) (200–342) (0.44–0.75) (−0.37–0.06)
Middle SDI
Armenia 0.689 14 0.38 25 0.63 0.65 6 0.38 10 0.61 0.60 8 0.38 15 0.64 0.69 1.06
(13–17) (0.35–0.46) (21–30) (0.52–0.74) (0.27–0.97) (5–8) (0.34–0.5) (8–12) (0.47–0.73) (0–0.97) (7–9) (0.34–0.42) (12–18) (0.52–0.76) (0.37–1.02)
Azerbaijan 0.683 34 0.48 41 0.47 −0.02 12 0.37 16 0.39 0.06 22 0.56 25 0.52 −0.06 1.33
(29–43) (0.4–0.64) (33–55) (0.36–0.64) (−0.18–0.17) (10–15) (0.3–0.48) (11–22) (0.28–0.52) (−0.18–0.37) (18–30) (0.46–0.78) (19–36) (0.39–0.76) (−0.26–0.18)
China 0.686 5900 0.42 7239 0.39 −0.08 3315 0.54 4212 0.52 −0.04 2586 0.35 3027 0.30 −0.14 0.58
(5254–6472) (0.37–0.46) (6012–8476) (0.32–0.45) (−0.22–0.07) (2642–3714) (0.42–0.6) (3178–5241) (0.4–0.64) (−0.22–0.19) (2244–3082) (0.31–0.42) (2395–3759) (0.24–0.38) (−0.32–0.07)
Indonesia 0.66 1607 1.02 1998 1.00 −0.02 487 0.65 677 0.70 0.09 1120 1.35 1321 1.25 −0.07 1.78
(1172–1850) (0.76–1.16) (1459–2389) (0.75–1.18) (−0.18–0.14) (396–581) (0.54–0.76) (493–891) (0.53–0.91) (−0.16–0.36) (687–1349) (0.85–1.61) (828–1665) (0.8–1.55) (−0.27–0.16)
Iran (Islamic Republic of) 0.67 220 0.42 341 0.49 0.16 91 0.34 147 0.41 0.21 129 0.50 195 0.56 0.12 1.38
(180–234) (0.35–0.45) (245–375) (0.36–0.53) (0.01–0.27) (80–97) (0.3–0.36) (112–163) (0.32–0.45) (0.04–0.34) (98–141) (0.39–0.55) (131–220) (0.39–0.64) (−0.06–0.24)
Iraq 0.671 97 0.60 159 0.70 0.17 41 0.53 74 0.68 0.28 56 0.67 85 0.72 0.08 1.06
(75–123) (0.47–0.77) (120–201) (0.54–0.86) (−0.07–0.43) (31–54) (0.4–0.7) (54–93) (0.5–0.84) (−0.03–0.67) (42–74) (0.5–0.9) (63–110) (0.55–0.92) (−0.18–0.42)
Philippines 0.623 733 1.31 1010 1.34 0.02 225 0.83 325 0.90 0.08 508 1.70 685 1.69 −0.01 1.88
(662–809) (1.19–1.48) (812–1225) (1.08–1.63) (−0.16–0.23) (196–257) (0.74–0.96) (243–421) (0.68–1.16) (−0.19–0.4) (446–580) (1.5–2) (513–880) (1.28–2.16) (−0.23–0.26)
Syrian Arab Republic 0.619 17 0.18 21 0.18 0.02 8 0.16 11 0.17 0.06 8 0.20 10 0.20 −0.03 1.16
(11–20) (0.12–0.22) (13–28) (0.12–0.24) (−0.22–0.31) (6–11) (0.12–0.21) (7–15) (0.12–0.24) (−0.24–0.45) (5–10) (0.11–0.26) (5–14) (0.11–0.27) (−0.26–0.27)
Thailand 0.687 475 0.70 577 0.58 −0.17 150 0.47 198 0.44 −0.06 325 0.87 379 0.68 −0.21 1.54
(408–589) (0.6–0.84) (433–793) (0.43–0.79) (−0.39–0.12) (124–185) (0.39–0.58) (142–275) (0.32–0.61) (−0.34–0.32) (269–421) (0.72–1.1) (274–559) (0.5–1.01) (−0.42–0.08)
Turkmenistan 0.67 11 0.37 16 0.40 0.09 5 0.33 7 0.37 0.13 7 0.40 9 0.42 0.06 1.13
(11–12) (0.34–0.39) (13–20) (0.32–0.5) (−0.12–0.36) (4–5) (0.29–0.37) (6–9) (0.29–0.47) (−0.11–0.45) (6–7) (0.36–0.43) (7–11) (0.33–0.53) (−0.16–0.34)
Uzbekistan 0.631 34 0.29 54 0.31 0.10 14 0.24 23 0.27 0.16 20 0.31 31 0.34 0.09 1.23
(32–37) (0.26–0.31) (45–65) (0.26–0.37) (−0.07–0.29) (12–16) (0.19–0.27) (17–29) (0.19–0.33) (−0.05–0.43) (18–22) (0.28–0.34) (26–37) (0.28–0.4) (−0.09–0.31)
Vietnam 0.617 971 1.41 1204 1.34 −0.04 359 1.22 474 1.23 0.01 612 1.53 730 1.42 −0.07 1.15
(803–1137) (1.19–1.65) (925–1533) (1.04–1.69) (−0.23–0.15) (258–434) (0.94–1.46) (334–613) (0.92–1.56) (−0.21–0.25) (487–751) (1.21–1.89) (530–967) (1.03–1.9) (−0.29–0.16)
Low‐middle SDI
Bangladesh 0.483 479 0.54 646 0.49 −0.08 193 0.42 253 0.38 −0.10 287 0.67 393 0.62 −0.08 1.63
(376–617) (0.43–0.68) (472–888) (0.37–0.68) (−0.26–0.13) (136–258) (0.3–0.55) (177–367) (0.26–0.55) (−0.33–0.18) (213–396) (0.51–0.91) (269–589) (0.42–0.92) (−0.28–0.2)
Bhutan 0.455 3 0.68 4 0.71 0.03 1 0.51 2 0.56 0.09 2 0.87 2 0.86 −0.01 1.55
(2–4) (0.53–0.92) (3–5) (0.53–0.97) (−0.14–0.22) (1–2) (0.33–0.72) (1–2) (0.35–0.82) (−0.14–0.36) (1–3) (0.64–1.22) (2–3) (0.63–1.21) (−0.19–0.22)
Cambodia 0.469 105 1.27 150 1.33 0.05 26 0.73 38 0.80 0.09 79 1.63 112 1.69 0.03 2.12
(69–133) (0.86–1.6) (100–192) (0.9–1.67) (−0.13–0.25) (19–33) (0.56–0.94) (27–48) (0.58–1) (−0.13–0.36) (48–102) (1.01–2.09) (65–150) (1.01–2.22) (−0.15–0.27)
Democratic People's Republic of Korea 0.558 148 0.58 165 0.52 −0.10 44 0.46 55 0.44 −0.05 104 0.67 110 0.59 −0.12 1.34
(116–186) (0.46–0.72) (130–206) (0.42–0.65) (−0.24–0.07) (31–65) (0.33–0.65) (40–76) (0.32–0.6) (−0.21–0.16) (77–139) (0.5–0.88) (83–146) (0.44–0.79) (−0.29–0.09)
India 0.566 5270 0.62 7075 0.63 0.02 1991 0.48 2687 0.49 0.03 3279 0.75 4388 0.75 0.00 1.53
(4583–5850) (0.53–0.68) (5979–8315) (0.53–0.73) (−0.13–0.18) (1683–2300) (0.4–0.55) (2179–3229) (0.4–0.59) (−0.18–0.28) (2665–3769) (0.61–0.86) (3319–5468) (0.58–0.94) (−0.2–0.22)
Kyrgyzstan 0.596 16 0.43 18 0.40 −0.07 4 0.26 5 0.25 0.00 11 0.56 13 0.51 −0.09 1.99
(14–17) (0.39–0.47) (15–21) (0.35–0.47) (−0.21–0.09) (4–5) (0.23–0.29) (4–6) (0.21–0.3) (−0.18–0.2) (10–13) (0.5–0.62) (11–15) (0.43–0.6) (−0.24–0.09)
Lao People's Democratic Republic 0.49 37 1.16 47 1.11 −0.04 10 0.67 14 0.68 0.02 27 1.59 33 1.50 −0.05 2.20
(24–48) (0.76–1.47) (31–61) (0.75–1.45) (−0.2–0.17) (7–14) (0.48–0.88) (10–18) (0.5–0.87) (−0.21–0.32) (15–36) (0.93–2.09) (19–45) (0.89–2.01) (−0.24–0.17)
Maldives 0.562 2 0.91 2 0.87 −0.05 1 1.12 2 1.12 −0.01 1 0.65 1 0.57 −0.12 0.51
(1–2) (0.73–1.06) (2–3) (0.68–1.07) (−0.23–0.15) (1–1) (0.89–1.36) (1–2) (0.86–1.41) (−0.23–0.26) (0–1) (0.43–0.79) (0–1) (0.39–0.72) (−0.3–0.11)
Mongolia 0.606 10 0.66 13 0.58 −0.11 4 0.52 6 0.50 −0.04 6 0.74 7 0.63 −0.15 1.25
(4–13) (0.24–0.85) (5–17) (0.22–0.79) (−0.3–0.16) (2–5) (0.22–0.69) (2–8) (0.22–0.69) (−0.29–0.26) (2–8) (0.22–1) (3–10) (0.2–0.89) (−0.36–0.14)
Myanmar 0.521 386 1.10 456 1.03 −0.06 106 0.67 134 0.68 0.02 280 1.43 323 1.28 −0.10 1.87
(276–480) (0.8–1.36) (342–565) (0.79–1.27) (−0.23–0.13) (78–140) (0.51–0.88) (100–171) (0.52–0.87) (−0.21–0.31) (179–356) (0.94–1.79) (217–411) (0.88–1.61) (−0.28–0.1)
Palestine 0.588 10 0.63 15 0.73 0.15 3 0.37 4 0.40 0.06 7 0.83 11 1.00 0.20 2.52
(8–11) (0.53–0.72) (11–18) (0.5–0.89) (−0.11–0.39) (2–3) (0.31–0.44) (3–5) (0.31–0.48) (−0.15–0.32) (6–8) (0.67–0.99) (7–14) (0.63–1.24) (−0.14–0.51)
Tajikistan 0.539 8 0.24 10 0.24 0.02 4 0.22 5 0.23 0.06 4 0.25 5 0.25 −0.01 1.07
(5–10) (0.14–0.3) (7–12) (0.14–0.31) (−0.19–0.3) (2–4) (0.13–0.28) (3–6) (0.13–0.3) (−0.2–0.38) (2–5) (0.12–0.32) (3–7) (0.13–0.33) (−0.23–0.27)
Timor‐Leste 0.514 5 0.89 8 1.00 0.12 1 0.46 2 0.57 0.24 4 1.34 6 1.44 0.07 2.54
(4–7) (0.63–1.18) (5–11) (0.68–1.33) (−0.09–0.37) (1–2) (0.31–0.68) (1–3) (0.38–0.78) (−0.03–0.59) (2–6) (0.85–1.84) (3–8) (0.89–1.96) (−0.15–0.32)
Low SDI
Afghanistan 0.343 92 0.90 118 0.89 −0.01 23 0.47 31 0.49 0.03 69 1.30 87 1.26 −0.03 2.60
(57–133) (0.6–1.27) (75–173) (0.62–1.24) (−0.19–0.22) (14–37) (0.28–0.76) (20–48) (0.31–0.72) (−0.19–0.33) (35–108) (0.74–1.99) (46–137) (0.76–1.88) (−0.22–0.23)
Nepal 0.422 103 0.60 154 0.70 0.17 33 0.40 54 0.53 0.30 70 0.79 101 0.86 0.09 1.63
(83–132) (0.49–0.75) (117–207) (0.53–0.93) (−0.07–0.42) (22–45) (0.26–0.55) (33–79) (0.32–0.78) (−0.05–0.67) (56–95) (0.63–1.04) (75–137) (0.64–1.16) (−0.14–0.36)
Pakistan 0.449 1030 1.12 1317 1.08 −0.03 419 0.91 542 0.90 −0.01 610 1.34 775 1.28 −0.05 1.42
(869–1214) (0.95–1.31) (1077–1610) (0.9–1.32) (−0.21–0.2) (325–523) (0.7–1.14) (388–723) (0.65–1.19) (−0.28–0.36) (473–756) (1.07–1.66) (569–1043) (0.96–1.69) (−0.28–0.3)
Yemen 0.412 49 0.51 72 0.54 0.06 16 0.32 23 0.35 0.07 33 0.69 49 0.73 0.05 2.08
(36–65) (0.38–0.69) (52–97) (0.4–0.73) (−0.12–0.3) (11–23) (0.23–0.48) (15–36) (0.23–0.53) (−0.17–0.37) (23–46) (0.5–0.97) (33–68) (0.51–1.01) (−0.15–0.33)

3.2.5. National comparison

Among Asian countries, 32 countries experienced a decreasing trend in the ThC death rate between 2010 and 2019; the greatest increase was detected in Armenia (increase in ASDR = 0.65 (95% CI: 0.27–0.97)) and the greatest decrease was detected in the Republic of Korea (decrease in ASDR = −0.43 (95% CI: −0.51 to −0.12)).

In 2019, the highest ASDR (per 100,000) of ThC was reported in Philippines (1.34), Vietnam (1.34), and Cambodia (1.33). The lowest ASDR of ThC was reported in the Syrian Arab Republic (0.18), Tajikistan (0.24), and Uzbekistan (0.31).

Among Asian men, the highest ASDR (per 100,000) of ThC was reported in Vietnam (1.23), Maldives (1.12), Pakistan (0.90), the Philippines (0.90), and Brunei Darussalam (0.90). The lowest ASDR of ThC was reported in the Syrian Arab Republic (0.17), Tajikistan (0.23), Kyrgyzstan (0.25), and Uzbekistan (0.27).

Among Asian women, the highest ASDR (per 100,000) of ThC was reported in the Philippines (1.69), Cambodia (1.69), Brunei Darussalam (1.53), and Lao People's Democratic Republic (1.50). The lowest ASDR of ThC was reported in the Syrian Arab Republic (0.20), Tajikistan (0.25), China (0.30), and Uzbekistan (0.34). Results in detail are presented in Table 6.

3.2.6. Male/female ratio

In 2019, the ASDR of ThC in the United Arab Emirates, Lebanon, China, and Maldives were reported to be higher in men than in women. In other countries, the incidence of ThC in women was higher than in men. The highest ratio was reported in Bahrain (2.72‐fold) and the lowest ratio was recorded in Maldives (0.51‐fold), while in 2010, the ASDR of ThC in China and Maldives were reported to be higher in men than in women. In other countries, the incidence of ThC in women was higher than in men; the highest ratio was reported in Qatar (2.95‐fold) and the lowest ratio was recorded in Maldives (0.58‐fold). Results in detail are presented in Table 6 and Figure 3.

3.3. Prevalence of THC in Asia

3.3.1. Compared with global data and continents

In Asia, the number of cases who lived with ThC increased from 759,981 (95% CI: 640,546–805,950) in 2010 to 982,341 (95% CI: 857,344–1,082,418) in 2019, which is a 1.3‐fold increase. In 2019, more than 53% (982,341/1,831,760) of ThC prevalence happened in Asian countries. During this period, the ASPR of ThC with an 8% change, increased from 17.94 (95% CI: 15.12–18.98) per 100,000 in 2010 to 19.42 (95% CI: 16.93–21.38) per 100,000 in 2019. Also, at the same time, this rate globally increased by 3% and Africa by 23%. This rate decreased by 1% in America and 2% in Europe (Figure 4 and Table 1).

In Asian men, the number of ThC prevalence increased from 205,125 (95% CI: 169,386–221,225) in 2010 to 285,342 (95% CI: 239,841–324,527) in 2019, which is over a 1.39‐fold increase. In 2019, approximately 29% (285,342/982,341) of patients who lived with ThC in Asia were men, which included 50.7% (285,342/562,741) of global male ThC prevalence cases. During this period, the ASPR of THC had a 16% change, increasing from 9.67 (95% CI: 7.98–10.41) per 100,000 in 2010 to 11.18 (95% CI: 9.42–12.69) per 100,000 in 2019; in the same time, this rate globally increased by 7%, in Africa by 34%, in America by 3%, and in Europe and by 1% (Table 4).

In Asian women, the number of ThC prevalence increased from 554,856 (95% CI: 447,358–595,190) in 2010 to 696,999 (95% CI: 582,544–783,841) in 2019, which is over a 1.25‐fold increase. In 2019, approximately 71% (696,999/982,341) of patients who lived with ThC in Asia were women, which included 54.9% (696,999/1,269,019) of global female ThC prevalence cases. During this period, the ASPR of ThC had a 5% change, increasing from 26.34 (95% CI: 21.31–28.20) per 100,000 in 2010 to 27.77 (95% CI: 23.15–31.19) per 100,000 in 2019; at the same time, this rate globally increased by 1% and in Africa by 19%. This rate decreased in America by 3% and in Europe by 4% (Table 5).

3.3.2. Age distribution

In 2019, age‐specific prevalence cases of ThC were peaking at 55 to 59 years generally and in males, and 60 to 64 in females. In all age groups, the prevalence cases of ThC in females were higher than in males (Figure 7). In 2019, there were 74,272 ThC patients aged ≥70 living in Asia, accounting for 7.56% of all ThC cases of all ages. This rate was 7.2% in men and 7.71% in women. Meanwhile, in the world, 184,567 patients ≥70 years lived with ThC, which includes 10.08% of ThC cases in all ages. This rate was 9.84% in men and 10.18% in women. Overall, 40.24% of ThC patients aged ≥70 years lived in Asia (Table 2).

FIGURE 7.

FIGURE 7

Age‐specific prevalence cases of ThC cancer among genders in Asia, 2019.

3.3.3. Within Asian regions

In 2019, the highest ASPR of ThC was observed in high‐income Asia Pacific countries (42.29 (95% CI: 35.62–49.33)), with a 35% decrease compared with 2010, while all Asian regions experienced an increasing trend of 18% (Southeast Asia and East Asia) and 27% (Central Asia and North Africa and the Middle East) (Figure 6).

In men, the highest ASPR of ThC was observed in high‐income Asia Pacific countries (22.20 (95% CI: 17.78–26.90)), with a 31% decrease compared with 2010, while all Asian regions experienced an increasing trend of 29% (East Asia) and 42% (North Africa and the Middle East).

In women, the highest ASPR of ThC was observed in high‐income Asia Pacific countries (62.48 (95% CI: 50.50–74.44)), with a 35% decrease compared with 2010, while all Asian regions experienced an increasing trend of 13% (East Asia) and 25% (Central Asia) (Figure 6).

3.3.4. Based on SDI

Among high SDI Asian countries, the Republic of Korea (57.73) and Saudi Arabia (50.55) have the highest ASPR of ThC, and Qatar (22.54) has the lowest rate. In this group, four countries experienced an upward trend from 5% to 38%, and seven countries reported a downward trend from 1% to 55% from 2010 to 2019.

Among high‐middle SDI Asian countries, Lebanon (68.50) had the highest ASPR of ThC, and Georgia (18.91) had the lowest rate. In this group, Bahrain and Oman had a downward trend of 7% and 13%, respectively. Other countries reported an upward trend from 5% (Turkey) to 35% (Sri Lanka).

Among middle SDI Asian countries, Vietnam (57.61) has the highest ASPR of ThC, and Uzbekistan (6.26) has the lowest rate. In this group, all countries experienced an upward trend from 11% (Indonesia) to 87% (Armenia) except Thailand, which reported a downward trend of 1% from 2010 to 2019.

Among low‐middle SDI Asian countries, Palestine (26.33) has the highest ASPR of ThC, and Tajikistan (2.51) has the lowest rate. In this group, all countries reported an upward trend from 1% (Democratic People's Republic of Korea) to 59% (Palestine). Among low SDI Asian countries, Pakistan (19.41) has the highest ASPR of ThC, and Nepal (12.17) has the lowest rate. In this group, all countries experienced an upward trend of 19% (Afghanistan) to 42% (Nepal). More details are presented in Table 7.

TABLE 7.

The prevalence distribution of thyroid cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019, by geographical region and SDI.

Location SDI 2019 Both Male Female F/M Ratio
2010 2019 % change 1990–2010 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000
High SDI
Brunei Darussalam 0.823 119 35.34 165 37.47 0.06 20 11.94 30 13.32 0.12 99 59.01 136 62.57 0.06 4.70
(97–143) (28.98–41.66) (129–208) (29.58–46.51) (−0.15–0.32) (16–25) (9.69–14.47) (23–39) (10.17–17.07) (−0.17–0.48) (79–122) (47.57–71.43) (101–178) (47.61–80.67) (−0.18–0.38)
Cyprus 0.841 408 29.37 452 25.61 −0.13 166 24.75 193 23.39 −0.05 242 33.75 258 27.87 −0.17 1.19
(335–468) (24.17–33.6) (365–562) (20.71–32.17) (−0.28–0.05) (126–204) (18.76–30.38) (138–256) (16.6–31.01) (−0.29–0.26) (198–291) (27.81–40.5) (198–353) (21.43–38.66) (−0.37–0.08)
Israel 0.803 2991 36.86 3436 34.09 −0.08 1038 26.72 1223 25.31 −0.05 1954 46.07 2213 42.23 −0.08 1.67
(2636–3365) (32.52–41.32) (2567–4494) (25.39–44.64) (−0.31–0.22) (829–1218) (21.41–31.34) (871–1672) (18.08–34.57) (−0.33–0.31) (1663–2264) (39.22–53.52) (1640–2947) (31.12–56.46) (−0.33–0.24)
Japan 0.87 83,303 39.67 76,771 35.51 −0.10 22,059 21.63 21,079 19.94 −0.08 61,244 57.14 55,691 50.82 −0.11 2.55
(76,730–89,153) (36.95–42.52) (63,058–92,419) (29.33–42.99) (−0.25–0.09) (19,533–24,580) (19.24–24.18) (15,911–27,535) (15.37–25.98) (−0.29–0.19) (55,920–66,394) (52.55–62.13) (44,003–69,105) (40.07–63.6) (−0.29–0.12)
Kuwait 0.851 748 31.56 1306 31.25 −0.01 203 13.74 461 19.24 0.40 545 60.60 845 47.85 −0.21 2.49
(652–849) (27.9–35.52) (1037–1644) (25.29–38.88) (−0.2–0.22) (167–243) (11.51–16.18) (338–621) (14.46–25.61) (0.04–0.85) (459–649) (51.86–70.32) (626–1155) (37.09–62.89) (−0.39–0.03)
Qatar 0.83 301 25.31 525 22.54 −0.11 148 13.60 255 13.01 −0.04 153 59.35 270 52.52 −0.12 4.04
(236–385) (20.42–30.82) (367–757) (16.34–30.84) (−0.32–0.18) (105–204) (9.58–18.62) (165–365) (8.55–18.42) (−0.37–0.37) (112–209) (45.45–76.97) (177–441) (36.54–77.33) (−0.37–0.24)
Republic of Korea 0.878 80,876 126.93 44,075 57.73 −0.55 19,447 59.56 10,884 27.33 −0.54 61,428 193.40 33,191 89.36 −0.54 3.27
(24,303–95,538) (37.62–150.47) (29,771–56,704) (37.52–74.76) (−0.66–0) (5872–23,746) (18.71–71.94) (7186–14,581) (17.89–36.28) (−0.66–0.03) (18,340–75,067) (55.06–238.07) (21,750–44,233) (54.62–119.68) (−0.67–0.14)
Saudi Arabia 0.805 9068 36.64 20,142 50.55 0.38 2303 15.79 6183 25.84 0.64 6765 68.09 13,959 88.58 0.30 3.43
(6563–11,335) (28.82–44.17) (13,443–28,317) (36.23–67.54) (0.02–0.81) (1784–2973) (12.45–20.07) (4272–9232) (18.43–35.92) (0.19–1.22) (4161–8664) (49.04–84.9) (7901–20,675) (58.17–125.03) (−0.07–0.77)
Singapore 0.861 2216 36.67 2537 31.55 −0.14 481 15.91 619 15.38 −0.03 1735 59.04 1918 49.27 −0.17 3.20
(1920–2526) (32.06–41.48) (1912–3263) (23.94–40.48) (−0.34–0.11) (402–574) (13.33–19.01) (460–862) (11.51–21.2) (−0.27–0.29) (1466–2020) (50.22–68.26) (1417–2510) (36.47–64.46) (−0.37–0.1)
Taiwan (Province of China) 0.868 12,132 40.19 14,466 42.24 0.05 3668 24.21 4682 27.28 0.13 8464 55.86 9784 56.76 0.02 2.08
(10,779–13,697) (35.93–45.21) (10,800–19,758) (31.3–57.91) (−0.23–0.44) (3065–4347) (20.5–28.33) (3360–6526) (19.84–37.53) (−0.19–0.55) (7286–9896) (48.44–64.79) (7085–13,437) (40.84–78.99) (−0.27–0.43)
United Arab Emirates 0.88 1653 24.78 3898 29.94 0.21 1181 19.08 2733 26.23 0.37 472 37.43 1165 40.83 0.09 1.56
(986–2369) (13.91–36.51) (1996–6221) (16.08–45.83) (−0.11–0.63) (608–1798) (10.21–28.77) (1280–4566) (12.69–42.64) (−0.03–0.95) (318–673) (20.11–57.52) (604–1849) (21.06–63.92) (−0.2–0.57)
High‐middle SDI
Bahrain 0.751 236 27.73 387 25.92 −0.07 61 9.77 115 10.46 0.07 175 52.91 272 51.73 −0.02 4.94
(188–283) (19.19–33.12) (291–499) (19.39–33.27) (−0.27–0.24) (49–78) (7.48–12.24) (79–161) (7.37–14.11) (−0.24–0.48) (129–218) (35.28–65.52) (195–373) (36.98–67.55) (−0.25–0.31)
Georgia 0.702 740 15.18 906 18.91 0.25 128 5.73 181 8.17 0.43 612 23.34 724 28.44 0.22 3.48
(629–854) (13–17.43) (702–1115) (14.49–23.27) (−0.03–0.56) (101–156) (4.57–7.01) (113–234) (5.24–10.44) (0.02–0.85) (509–723) (19.49–27.56) (556–904) (21.98–35.53) (−0.07–0.57)
Jordan 0.731 1353 26.11 2750 29.21 0.12 310 11.41 769 14.46 0.27 1043 42.00 1982 46.20 0.10 3.19
(1112–1653) (21.54–31.75) (2123–3579) (22.66–38.04) (−0.11–0.4) (243–382) (8.92–14.1) (554–1043) (10.54–19.51) (−0.08–0.73) (818–1329) (33.13–53.18) (1404–2789) (33.18–64.57) (−0.17–0.47)
Kazakhstan 0.723 3132 18.61 4690 23.60 0.27 641 8.10 949 10.17 0.26 2491 27.53 3742 35.25 0.28 3.46
(2803–3504) (16.74–20.73) (3854–5711) (19.37–28.71) (0.04–0.58) (542–773) (6.87–9.78) (736–1267) (7.93–13.51) (−0.02–0.66) (2170–2829) (24.13–31.13) (3035–4606) (28.58–43.44) (0.02–0.6)
Lebanon 0.708 2206 52.94 3727 68.50 0.29 522 26.73 1019 40.26 0.51 1684 76.12 2708 93.81 0.23 2.33
(1713–2776) (41.22–66.77) (2593–5084) (48.1–93.3) (−0.03–0.66) (393–676) (20.3–34.33) (693–1370) (27.55–53.79) (0.11–1.02) (1214–2217) (54.89–100.68) (1767–3910) (61.51–136.48) (−0.11–0.66)
Malaysia 0.737 6868 26.60 11,091 34.64 0.30 1560 11.88 2889 17.67 0.49 5308 42.02 8202 52.72 0.25 2.98
(5928–8086) (23.06–31.21) (8112–14,685) (25.42–45.81) (−0.03–0.73) (1274–1923) (9.73–14.65) (2060–3931) (12.61–24.07) (0.07–1.02) (4418–6407) (35.14–50.65) (5776–11,152) (37.37–72.03) (−0.09–0.74)
Oman 0.783 636 30.46 984 26.47 −0.13 180 13.68 322 12.35 −0.10 457 55.72 662 50.81 −0.09 4.12
(457–754) (23.08–35.47) (721–1300) (20.14–32.74) (−0.29–0.09) (138–218) (11.11–16.44) (214–475) (8.68–16.95) (−0.35–0.27) (296–566) (37.76–67.52) (425–911) (35.73–67.23) (−0.3–0.23)
Sri Lanka 0.69 4513 20.34 7099 27.54 0.35 1120 10.66 1831 15.03 0.41 3394 29.14 5268 38.80 0.33 2.58
(3877–5548) (17.47–25.09) (4928–10,294) (19.14–39.71) (−0.05–0.91) (908–1395) (8.73–13.15) (1212–2610) (10.04–21.33) (−0.06–1.01) (2796–4422) (24.11–38.02) (3585–7785) (26.51–57.1) (−0.08–0.94)
Turkey 0.748 20,738 27.56 27,170 29.04 0.05 6163 16.26 9131 19.38 0.19 14,575 38.31 18,039 38.20 0.00 1.97
(17,083–24,773) (22.74–32.69) (20,659–35,897) (22.18–38.23) (−0.22–0.41) (4977–7681) (13.14–20.19) (6728–12,900) (14.28–27.23) (−0.16–0.64) (11,456–17,715) (30.13–46.46) (13,388–24,219) (28.4–51.14) (−0.28–0.38)
Middle SDI
Armenia 0.689 321 9.06 658 16.98 0.87 88 5.49 174 9.97 0.82 233 12.02 484 22.84 0.90 2.29
(283–398) (8.06–11.15) (531–800) (13.76–20.58) (0.46–1.35) (73–151) (4.57–9.09) (135–220) (7.87–12.52) (0.18–1.37) (203–268) (10.47–13.83) (387–599) (18.29–28.19) (0.43–1.43)
Azerbaijan 0.683 1077 11.28 1531 12.96 0.15 220 4.76 353 6.15 0.29 857 17.24 1179 19.26 0.12 3.13
(877–1309) (9.32–13.64) (1175–1979) (9.92–16.63) (−0.1–0.48) (167–284) (3.7–6.09) (236–487) (4.14–8.52) (−0.08–0.75) (665–1086) (13.68–21.83) (845–1591) (14–25.66) (−0.18–0.51)
China 0.686 228,906 13.51 310,328 16.17 0.20 80,801 9.41 118,423 12.22 0.30 148,106 17.77 191,904 20.21 0.14 1.65
(204,094–262,191) (12.05–15.43) (255,041–382,138) (13.28–19.83) (−0.02–0.45) (68,490–92,183) (8.02–10.72) (89,065–149,034) (9.29–15.34) (0–0.68) (127,562–178,960) (15.29–21.35) (145,570–253,044) (15.32–26.45) (−0.14–0.48)
Indonesia 0.66 35,011 15.27 47,136 16.93 0.11 6747 6.05 10,604 7.75 0.28 28,264 24.47 36,532 26.12 0.07 3.37
(22,706–42,901) (9.95–18.62) (31,955–60,457) (11.57–21.58) (−0.14–0.47) (5129–8258) (4.59–7.37) (7512–14,621) (5.51–10.59) (−0.06–0.76) (16,421–35,824) (14.2–30.78) (21,901–49,115) (15.71–35.07) (−0.21–0.51)
Iran (Islamic Republic of) 0.67 14,839 20.61 27,337 30.19 0.46 3926 10.75 7875 17.03 0.58 10,913 30.53 19,462 43.43 0.42 2.55
(10,198–16,496) (14.23–22.97) (16,709–31,333) (18.75–34.55) (0.27–0.64) (2876–4520) (8.05–12.32) (5156–9410) (11.25–20.26) (0.3–0.89) (7365–12,430) (20.69–34.73) (11,236–23,044) (25.73–51.01) (0.18–0.64)
Iraq 0.671 5726 23.18 10,904 32.60 0.41 1380 11.19 2928 17.32 0.55 4346 35.57 7976 48.33 0.36 2.79
(4147–7751) (16.94–31.38) (7428–15,294) (22.45–45.18) (0.05–0.87) (989–1901) (7.96–15.52) (1953–4182) (11.82–24.13) (0.1–1.19) (2993–6172) (24.61–50.82) (5088–11,693) (31.49–68.98) (−0.03–0.87)
Philippines 0.623 20,333 25.39 29,778 29.61 0.17 4172 10.60 6615 13.29 0.25 16,161 40.05 23,163 45.97 0.15 3.46
(17,328–23,408) (21.55–29.28) (22,714–39,024) (22.63–38.56) (−0.11–0.52) (3403–5012) (8.64–12.68) (4667–8845) (9.32–17.82) (−0.12–0.75) (13,215–19,115) (32.74–47.35) (16,523–32,079) (32.84–63.47) (−0.16–0.59)
Syrian Arab Republic 0.619 1034 6.66 1139 7.63 0.15 345 4.26 381 5.06 0.19 690 9.24 757 10.13 0.10 2.00
(742–1290) (4.46–8.39) (733–1576) (4.95–10.56) (−0.16–0.52) (250–454) (2.94–5.66) (245–553) (3.32–7.24) (−0.18–0.72) (465–895) (5.63–12.11) (449–1061) (5.96–14.06) (−0.21–0.5)
Thailand 0.687 17,508 21.38 20,577 21.14 −0.01 4472 11.30 5944 12.83 0.14 13,036 30.75 14,634 28.84 −0.06 2.25
(13,893–27,201) (17.14–32.59) (13,389–36,196) (13.94–37.43) (−0.33–0.4) (3470–6054) (8.76–15.31) (3917–9622) (8.63–21.08) (−0.24–0.69) (10,032–21,892) (23.76–50.67) (9177–28,105) (18.04–56.81) (−0.4–0.36)
Turkmenistan 0.67 389 9.35 635 12.59 0.35 107 5.10 188 7.34 0.44 282 13.30 447 17.61 0.32 2.40
(348–435) (8.43–10.41) (488–824) (9.71–16.32) (0.04–0.77) (87–128) (4.18–6.06) (139–246) (5.47–9.61) (0.08–0.89) (247–322) (11.73–15.09) (339–588) (13.34–23.15) (0.01–0.77)
Uzbekistan 0.631 890 3.92 1911 6.26 0.60 244 2.15 508 3.43 0.60 646 5.51 1402 8.79 0.60 2.57
(799–1004) (3.53–4.38) (1534–2330) (5.03–7.65) (0.26–0.99) (203–291) (1.78–2.56) (384–639) (2.54–4.31) (0.21–1.08) (558–748) (4.81–6.32) (1094–1738) (6.94–10.84) (0.22–1.03)
Vietnam 0.617 42,287 46.42 64,088 57.61 0.24 10,065 23.76 16,543 30.94 0.30 32,222 67.91 47,545 83.48 0.23 2.70
(23,507–56,042) (27.31–60.81) (38,833–87,569) (35.62–77.76) (−0.06–0.64) (5609–13,667) (14.38–31.61) (9828–23,789) (18.97–43.49) (−0.05–0.76) (16,521–44,547) (36.38–92.91) (25,548–66,947) (45.23–116.31) (−0.1–0.66)
Low‐middle SDI
Bangladesh 0.483 10,582 8.08 17,036 10.74 0.33 1984 3.14 3184 4.19 0.33 8598 13.15 13,852 17.02 0.29 4.07
(7607–15,478) (5.99–11.46) (11,359–25,991) (7.25–16.19) (0–0.79) (1338–2898) (2.14–4.53) (2117–4996) (2.78–6.51) (−0.04–0.83) (5822–13,468) (9.22–19.61) (8655–22,397) (10.87–27.25) (−0.06–0.8)
Bhutan 0.455 68 10.59 104 13.97 0.32 14 4.24 23 5.98 0.41 54 17.98 82 22.86 0.27 3.82
(45–99) (7.25–15.11) (65–159) (9.08–20.68) (−0.02–0.76) (9–21) (2.61–6.42) (13–36) (3.42–9.57) (−0.02–0.92) (33–80) (11.4–26.6) (48–132) (13.97–35.73) (−0.08–0.75)
Cambodia 0.469 1977 17.09 3474 23.33 0.37 301 5.80 573 8.43 0.46 1676 26.25 2901 36.12 0.38 4.28
(1186–2710) (10.18–23.31) (2075–4924) (13.94–32.81) (0.05–0.81) (209–422) (4.02–8.17) (396–784) (5.82–11.37) (0.06–0.99) (928–2362) (14.71–36.76) (1606–4192) (20.01–52.12) (0.03–0.87)
Democratic People's Republic of Korea 0.558 5250 18.14 5900 18.38 0.01 1119 8.20 1482 8.98 0.09 4130 27.80 4419 28.24 0.02 3.14
(3608–7563) (12.55–25.97) (4056–8544) (12.54–26.97) (−0.24–0.35) (713–1777) (5.26–12.93) (923–2287) (5.66–13.83) (−0.2–0.5) (2644–6319) (17.63–42.25) (2815–6826) (17.99–44.66) (−0.27–0.43)
India 0.566 113,286 9.78 169,543 12.14 0.24 23,802 4.19 37,508 5.41 0.29 89,483 15.61 132,035 19.11 0.22 3.53
(93,562–127,781) (8.1–11) (136,587–205,896) (9.79–14.74) (0.02–0.51) (20,423–26,877) (3.6–4.72) (29,944–45,585) (4.33–6.6) (0.03–0.61) (69,006–103,229) (12.1–17.96) (99,160–167,160) (14.36–24.16) (−0.03–0.56)
Kyrgyzstan 0.596 456 9.76 654 11.18 0.14 76 3.24 119 4.11 0.27 380 15.53 536 17.42 0.12 4.23
(397–521) (8.55–11.09) (526–798) (9.05–13.56) (−0.08–0.43) (63–92) (2.68–3.91) (92–151) (3.21–5.2) (−0.02–0.63) (325–445) (13.31–18.13) (423–671) (13.85–21.74) (−0.13–0.43)
Lao People's Democratic Republic 0.49 608 12.74 952 15.56 0.22 101 4.31 170 5.68 0.32 507 20.99 782 25.32 0.21 4.46
(351–870) (7.35–18.01) (559–1416) (9.29–22.83) (−0.07–0.6) (65–143) (2.8–6.06) (110–241) (3.81–8.08) (−0.04–0.87) (256–749) (10.67–30.73) (414–1201) (13.29–38.03) (−0.11–0.65)
Maldives 0.562 52 19.65 103 23.32 0.19 26 19.02 62 24.26 0.28 26 20.33 41 22.56 0.11 0.93
(44–60) (16.89–22.97) (80–135) (18.53–29.4) (−0.04–0.48) (21–33) (15.26–24.03) (47–88) (18.38–31.96) (−0.04–0.68) (21–32) (16.35–24.87) (30–55) (16.9–29.3) (−0.16–0.43)
Mongolia 0.606 167 8.03 281 9.07 0.13 57 4.96 97 5.99 0.21 111 10.60 184 11.47 0.08 1.92
(109–214) (4.35–10.61) (166–388) (4.92–12.68) (−0.17–0.54) (29–79) (2.3–6.9) (51–142) (2.97–8.69) (−0.16–0.74) (67–146) (5.2–14.17) (106–269) (5.94–16.55) (−0.23–0.51)
Myanmar 0.521 6774 14.44 9942 17.84 0.24 1119 5.17 1844 7.23 0.40 5654 22.64 8098 26.98 0.19 3.73
(4192–9188) (9.04–19.43) (6626–13,643) (11.95–24.42) (−0.1–0.67) (737–1556) (3.51–7.18) (1260–2609) (4.98–10.15) (−0.02–1) (3145–7906) (12.65–31.37) (4914–11,395) (16.41–37.86) (−0.15–0.69)
Palestine 0.588 414 16.51 922 26.33 0.59 76 5.93 150 8.59 0.45 339 26.54 771 44.19 0.66 5.15
(344–492) (13.85–19.5) (636–1173) (18.46–32.91) (0.18–1.04) (60–93) (4.69–7.37) (115–191) (6.54–11.02) (0.09–0.92) (272–414) (21.59–31.82) (503–1010) (29.19–56.37) (0.15–1.22)
Tajikistan 0.539 115 2.16 188 2.51 0.16 36 1.30 59 1.55 0.19 80 3.02 129 3.43 0.13 2.21
(97–137) (1.77–2.6) (147–242) (1.95–3.21) (−0.11–0.5) (28–44) (0.98–1.64) (43–77) (1.11–2.06) (−0.14–0.64) (64–98) (2.38–3.73) (98–170) (2.59–4.48) (−0.15–0.51)
Timor‐Leste 0.514 75 9.87 136 14.33 0.45 12 3.01 23 4.78 0.59 63 17.02 113 24.29 0.43 5.08
(38–107) (5.23–14.03) (75–197) (8.19–20.65) (0.06–1.07) (6–19) (1.45–4.75) (12–35) (2.59–7.16) (0.15–1.4) (32–92) (8.85–24.76) (60–168) (12.92–35.99) (0.03–1.08)
Low SDI
Afghanistan 0.343 1924 11.53 3253 13.74 0.19 246 2.93 472 3.84 0.31 1678 19.70 2781 23.72 0.20 6.17
(793–3380) (5.1–19.41) (1487–5607) (6.66–23.08) (−0.1–0.6) (140–433) (1.65–5.08) (281–779) (2.31–6.34) (−0.04–0.85) (586–3057) (7.44–34.68) (1077–5042) (9.72–41.39) (−0.1–0.63)
Nepal 0.422 2031 8.60 3423 12.17 0.42 286 2.63 526 4.19 0.59 1745 14.06 2896 18.87 0.34 4.51
(1446–2921) (6.24–12.18) (2327–4897) (8.24–17.14) (0.05–0.93) (172–427) (1.59–3.87) (310–806) (2.48–6.4) (0.14–1.23) (1205–2569) (9.91–20.64) (1923–4306) (12.51–27.7) (−0.03–0.86)
Pakistan 0.449 21,988 15.36 36,361 19.41 0.26 4563 6.53 7734 8.51 0.30 17,425 24.68 28,626 30.68 0.24 3.60
(16,616–28,109) (11.84–19.39) (25,890–50,429) (14.17–26.2) (−0.1–0.76) (3359–6032) (4.86–8.6) (5418–11,109) (5.94–12.17) (−0.12–0.92) (12,163–23,458) (17.52–32.6) (18,610–43,193) (20.43–45.46) (−0.18–0.89)
Yemen 0.412 1638 10.92 2806 13.26 0.21 301 3.87 511 4.71 0.22 1337 18.04 2295 21.71 0.20 4.61
(1019–2478) (6.97–16.26) (1699–4195) (8.36–19.62) (−0.1–0.61) (190–469) (2.45–6.03) (315–816) (2.87–7.47) (−0.14–0.71) (779–2137) (11.02–27.83) (1288–3605) (12.85–33.28) (−0.13–0.63)

3.3.5. National comparison

Among Asian countries, 10 countries experienced a decreasing trend in the ThC prevalence rate between 2010 and 2019; the greatest increase was detected in Armenia (increase in ASPR = 0.87 (95% CI: 0.46–1.35)) and the greatest decrease was detected in the Republic of Korea (decrease in ASPR = −0.55 (95% CI: −0.66–0.00)) (Figure 2).

In 2019, the highest ASPR (per 100,000) of ThC was reported in Lebanon (68.50), the Republic of Korea (57.73), Vietnam (57.61), and Saudi Arabia (50.55). The lowest ASPR of ThC was reported in Tajikistan (2.51), Uzbekistan (6.26), the Syrian Arab Republic (7.63), and Mongolia (9.07).

In Asian men, the highest ASPR (per 100,000) of ThC was reported in Lebanon (40.26), Vietnam (30.94), the Republic of Korea (27.33), and Taiwan (Province of China) (27.28). The lowest ASPR (per 100,000) of ThC was reported in Tajikistan (1.55), Uzbekistan (3.43), and Afghanistan (3.84).

In women, the highest ASPR (per 100,000) of ThC was reported in Lebanon (93.81), Republic of Korea (89.36), Saudi Arabia (88.58), and Vietnam (83.48) The lowest ASPR (per 100,000) of ThC was reported in Tajikistan (3.43), Uzbekistan (8.79), Syrian Arab Republic (10.13), and Mongolia (11.47). Results in detail are presented in Table 7.

3.3.6. Male/female ratio

In 2010, the ASPR of ThC in women was higher than in men in all countries, and in 2019, the ASPR of ThC in Maldives was reported to be higher in men than in women. In other countries, the prevalence of ThC in women was higher than in men. The highest ratio was reported in Afghanistan (6.17‐fold) and the lowest ratio was recorded in Maldives (0.93‐fold) (Figure 3).

3.4. Burden of THC in Asia

3.4.1. Comparison with global data and continents

In Asia, the number of ThC DALYs increased from 624,971 (95% CI: 545,913–666,046) in 2010 to 750,984 (95% CI: 665,083–819,813) in 2019, which is a 1.2‐fold increase. In 2019, approximately 61% (750,984/1,231,841) of ThC DALYs happened in Asian countries. During this period, the DALYs ASR of ThC had a 4% change, decreasing from 16.10 (95% CI: 14.08–17.12) per 100,000 in 2010 to 15.39 (95% CI: 13.60–16.79) per 100,000 in 2019. In the same period, this rate globally decreased by 4%, in Africa by 1%, in America by 2%, and in Europe by 10% (Figure 4 and Table 1).

In Asian men, the number of ThC DALYs increased from 256,437 (95% CI: 217,071–275,000) in 2010 to 316,821 (95% CI: 272,355–354,527) in 2019, which is over a 1.24‐fold increase. In 2019, approximately 42% (316,821/750,984) of ThC DALYs in Asia occurred in men, which included 62.14% (316,821/509,842) of global male ThC DALYs cases. During this period, the DALYs ASR of ThC had a 2% change, decreasing from 13.54 (95% CI: 11.49–14.46) per 100,000 in 2010 to 13.30 (95% CI: 11.41–14.88) per 100,000 in 2019. In the same period, this rate globally decreased by 2%, in Europe by 7%. This rate increased in Africa and America by 3% and 2%, respectively (Table 4).

In Asian women, the number of ThC DALYs increased from 368,534 (95% CI: 304,476–400,999) in 2010 to 434,163 (95% CI: 362,794–486,695) in 2019, which is approximately a 1.18‐fold increase. In 2019, more than 57% (434,163/750,984) of DALYs related to ThC in Asia were women, which included 60.13% (434,163/721,999) of global female ThC DALYs cases. During this period, the DALYs ASR of ThC had a 6% change, decreasing from 18.64 (95% CI: 15.61–20.23) per 100,000 in 2010 to 17.48 (95% CI: 14.65–19.64) per 100,000 in 2019. At the same time, this rate globally decreased by 6%, in American and African countries by 4%, and in European countries by 12% (Table 5).

3.4.2. Age distribution

In 2019, DALY cases of ThC were peaking at 75 to 79 generally and in females, and 85 years and higher in males. In all age groups, DALY cases of ThC in females were higher than in females, except in ages 80 to 84 years and 85 years and higher, which in males was higher (Figure 8). In 2019, 178,092 DALYs were attributed to ThC in Asians aged ≥70 years, accounting for 62.38% of the burden of ThC in all ages. This rate was 23.20% in men and 24.09% in women. Meanwhile, in the world, 318,786 DALY cases were diagnosed due to ThC in people ≥70 years old, which includes 25.88% of the burden caused by ThC in all ages. This rate was 24.36% in men and 26.95% in women. In general, 55.87% of the burden caused by ThC has been borne by the elderly ≥70 years (Table 2).

FIGURE 8.

FIGURE 8

Age‐specific DALYs cases of ThC cancer among genders in Asia, 2019.

3.4.3. Within Asian regions

In 2019, the highest DALYs ASR of ThC was observed in Southeast Asia countries (25.34 (95% CI: 21.37–28.88)), with a 4% decrease compared with 2010. Central Asia and North Africa and the Middle East experienced an increasing trend of 3% and 2%, respectively. Other regions recorded a decreasing trend of 1% (South Asia) to 31% (high‐income Asia Pacific) (Figure 6 and Table 1).

In men, the highest DALYs ASR of ThC was observed in Southeast Asia countries (18.99 (95% CI: 15.96–22.24)) with a 4% increase compared with 2010. Central Asia and North Africa and the Middle East had an increasing trend of 7% and 10%. South Asia had a stable trend. High‐income Asia Pacific countries and East Asia countries reported a decreasing trend of 31% and 2%, respectively (Table 4).

In women, the highest DALYs ASR of ThC was observed in Southeast Asia countries (30.87 (95% CI: 23.84–35.46)), with an 8% decrease compared with 2010. Central Asia had a stable trend and other regions recorded a decreasing trend of 2 (South Asia) to 12% (East Asia) (Table 5).

3.4.4. Based on SDI

In 2019, among high SDI Asian countries, Brunei Darussalam (26.03) and the United Arab Emirates (22.60) have the highest DALYs ASR of ThC, and Singapore (10.43) and Japan (10.96) have the lowest rate. In this group, all countries experienced a downward trend from 2% (Taiwan (Province of China)) to 52% (Republic of Korea) from 2010 to 2019. Among high‐middle SDI Asian countries, Malaysia (23.10) and Lebanon (20.19) have the highest DALYs ASR of ThC, and Oman (11.85) has the lowest rate. In this group, Malaysia had a stable trend. Five countries experienced a downward trend and three countries reported an upward trend from 2010 to 2019. In middle SDI Asian countries, Vietnam (36.32) and the Philippines (34.27) have the highest DALYs ASR of ThC, and the Syrian Arab Republic (4.62) and Uzbekistan (7.42) have the lowest rate. In this group, seven countries experienced an upward trend from 3% (Philippines) to 61% (Armenia), and Vietnam, Indonesia, and Azerbaijan reported a decreasing trend of 4%, China by 7%, and Thailand by 16% from 2010 to 2019.

Among low‐middle SDI Asian countries, Cambodia (32.50) has the highest ASPR of THC, and Tajikistan (5.35) has the lowest rate. In this group, eight countries reported a downward trend from 1% (India) to 10% (Mongolia), and five countries experienced an upward trend from 1% (Tajikistan) to 15% (Timor‐Leste and Palestine) from 2010 to 2019.

Among low SDI Asian countries, Pakistan (32.29) has the highest DALY ASR of ThC, and Yemen (14.19) has the lowest rate. In this group, Nepal and Yemen reported an increasing trend of 14% and 8%, and Pakistan and Afghanistan experienced a downward trend of 2% and 3%, respectively, from 2010 to 2019. More details are presented in Table 8.

TABLE 8.

The DALY distribution of thyroid cancer in Asian countries in 2010 and 2019 and the temporal trends between 2010 and 2019, by geographical region and SDI.

Location SDI 2019 Both Male Female F/M Ratio
2010 2019 % change 1990–2010 2010 2019 % change 2010–2019 2010 2019 % change 2010–2019
Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000 Number ASR per 1,000,000
High SDI
Brunei Darussalam 0.823 58 27.08 81 26.03 −0.04 18 17.38 25 17.43 0.00 40 35.78 56 34.02 −0.05 1.95
(49–67) (22.05–30.92) (66–96) (21.17–30.3) (−0.18–0.11) (15–21) (14.59–20.13) (20–32) (14.17–21.21) (−0.19–0.24) (31–48) (27.44–42.26) (43–69) (26.45–41.69) (−0.21–0.13)
Cyprus 0.841 195 13.95 211 11.38 −0.18 88 13.53 99 11.36 −0.16 107 14.26 112 11.32 −0.21 1.00
(157–220) (11.32–15.62) (173–252) (9.38–13.59) (−0.3 to −0.04) (67–101) (10.41–15.44) (76–121) (8.7–13.91) (−0.31–0.02) (81–125) (11.04–16.75) (88–139) (8.97–14.08) (−0.36 to −0.01)
Israel 0.803 1665 19.47 1826 16.65 −0.14 686 17.51 775 15.34 −0.12 979 20.99 1051 17.67 −0.16 1.15
(1454–1811) (17.01–21.21) (1597–2064) (14.51–18.81) (−0.24 to −0.04) (539–769) (13.77–19.66) (648–900) (12.79–17.77) (−0.24–0.02) (863–1083) (18.58–23.25) (891–1226) (14.99–20.67) (−0.27 to −0.03)
Japan 0.87 33,764 12.50 34,347 10.96 −0.12 12,742 10.71 12,651 9.29 −0.13 21,022 13.99 21,697 12.37 −0.12 1.33
(29,178–36,742) (11.09–13.64) (28,947–38,324) (9.64–12.28) (−0.17 to −0.06) (11,084–13,590) (9.49–11.44) (10,750–14,165) (8.18–10.51) (−0.19 to −0.04) (17,676–23,206) (12.3–15.49) (17,539–24,613) (10.7–14.18) (−0.17 to −0.04)
Kuwait 0.851 243 14.40 372 12.70 −0.12 102 9.79 193 11.30 0.15 141 22.07 179 14.78 −0.33 1.31
(218–270) (12.9–15.87) (303–459) (10.41–15.31) (−0.26–0.06) (89–116) (8.51–11.1) (146–249) (8.63–14.44) (−0.11–0.49) (122–162) (19.27–24.89) (139–236) (11.69–19.07) (−0.46 to −0.16)
Qatar 0.83 91 15.36 137 11.47 −0.25 56 10.73 86 8.61 −0.20 34 27.62 52 20.50 −0.26 2.38
(71–112) (12.27–18.29) (99–194) (8.71–15.23) (−0.41 to −0.03) (40–74) (7.41–13.92) (56–123) (5.84–12.04) (−0.43–0.11) (26–45) (20.55–34.54) (35–81) (15.04–27.84) (−0.45–0.06)
Republic of Korea 0.878 21,708 34.42 13,779 16.56 −0.52 8442 27.77 5065 12.69 −0.54 13,266 39.86 8714 19.92 −0.50 1.57
(8014–25,086) (12.96–39.75) (9787–16,466) (11.45–19.76) (−0.59 to −0.12) (3056–9637) (10.76–31.45) (3588–6223) (9.06–15.36) (−0.63 to −0.15) (4991–15,930) (14.57–48.25) (5787–10,851) (12.82–24.67) (−0.6 to −0.02)
Saudi Arabia 0.805 3337 19.49 5380 18.92 −0.03 1365 14.16 2475 15.02 0.06 1972 27.20 2905 24.82 −0.09 1.65
(2700–3966) (16.71–22.2) (3862–7281) (14.49–24) (−0.22–0.19) (1130–1655) (11.99–16.64) (1801–3381) (11.39–19.17) (−0.17–0.33) (1350–2456) (21.97–32.35) (1896–4176) (18.01–32.91) (−0.31–0.18)
Singapore 0.861 677 12.84 811 10.43 −0.19 240 9.37 314 8.27 −0.12 437 16.12 497 12.61 −0.22 1.52
(604–764) (11.54–14.33) (693–964) (8.95–12.38) (−0.28 to −0.08) (211–278) (8.27–10.77) (261–395) (6.92–10.3) (−0.25–0.04) (379–497) (13.98–18.21) (411–590) (10.45–14.97) (−0.32 to −0.08)
Taiwan (Province of China) 0.868 4330 14.46 5301 14.22 −0.02 1808 12.23 2239 12.56 0.03 2522 16.58 3062 15.68 −0.05 1.25
(3903–4716) (13.07–15.75) (4010–6962) (10.86–18.68) (−0.24–0.26) (1595–2011) (10.84–13.54) (1649–2958) (9.33–16.53) (−0.23–0.35) (2230–2826) (14.7–18.51) (2284–4018) (11.62–20.74) (−0.28–0.24)
United Arab Emirates 0.88 907 24.78 1873 22.60 −0.09 732 22.47 1531 24.00 0.07 174 28.58 343 18.71 −0.35 0.78
(520–1303) (12.92–36.04) (966–2948) (11.68–34.23) (−0.31–0.19) (386–1092) (11.33–33.27) (716–2473) (11.72–37.34) (−0.2–0.43) (111–244) (12.95–45.48) (174–544) (9.26–30) (−0.5 to −0.05)
High‐middle SDI
Bahrain 0.751 99 19.40 142 14.63 −0.25 36 10.50 57 8.44 −0.20 63 29.42 85 23.00 −0.22 2.72
(73–116) (12.35–23.01) (109–183) (10.42–18.65) (−0.4 to −0.04) (29–44) (8.23–12.46) (41–78) (6.16–11.06) (−0.41–0.08) (41–77) (16.38–35.9) (59–111) (14.13–30.05) (−0.39–0.03)
Georgia 0.702 706 13.01 825 15.42 0.19 224 9.62 295 12.66 0.32 482 15.74 530 17.72 0.13 1.40
(626–780) (11.5–14.38) (635–991) (11.96–18.55) (−0.04–0.43) (173–259) (7.47–11.06) (173–362) (7.58–15.48) (−0.04–0.63) (416–543) (13.55–17.9) (421–643) (13.81–21.56) (−0.11–0.38)
Jordan 0.731 619 15.60 1084 14.39 −0.08 230 11.05 444 10.63 −0.04 390 20.56 640 18.54 −0.10 1.74
(532–728) (13.36–18.32) (877–1371) (11.71–18.22) (−0.25–0.13) (190–270) (9.11–13.17) (326–588) (7.84–14.21) (−0.28–0.26) (315–483) (16.72–25.45) (470–866) (13.71–24.97) (−0.3–0.16)
Kazakhstan 0.723 2778 17.85 3031 16.32 −0.09 983 14.20 1051 12.69 −0.11 1796 20.46 1980 19.00 −0.07 1.50
(2597–3019) (16.7–19.44) (2540–3620) (13.77–19.41) (−0.22–0.09) (890–1137) (12.93–16.8) (843–1374) (10.32–16.51) (−0.27–0.12) (1645–1976) (18.73–22.52) (1631–2391) (15.74–22.93) (−0.22–0.11)
Lebanon 0.708 798 18.98 1070 20.19 0.06 335 16.61 467 19.20 0.16 464 21.09 603 21.16 0.00 1.10
(663–982) (15.84–23.4) (817–1377) (15.5–25.89) (−0.14–0.28) (269–422) (13.29–20.95) (332–604) (13.77–25.01) (−0.08–0.42) (365–596) (16.64–27.18) (441–844) (15.43–29.61) (−0.23–0.27)
Malaysia 0.737 4829 23.02 6583 23.10 0.00 1652 15.10 2520 17.26 0.14 3177 30.80 4063 29.00 −0.06 1.68
(4314–5629) (20.45–27.08) (5087–8478) (17.83–29.86) (−0.21–0.26) (1421–1965) (12.91–17.93) (1861–3351) (12.68–22.87) (−0.15–0.49) (2738–3784) (26.58–36.92) (3018–5446) (21.68–38.89) (−0.28–0.22)
Oman 0.783 223 15.09 284 11.85 −0.21 95 11.05 129 8.93 −0.19 128 20.70 155 16.28 −0.21 1.82
(173–254) (12.4–16.94) (216–359) (9.68–14.02) (−0.34 to −0.06) (78–109) (9.35–12.73) (93–182) (6.74–11.3) (−0.38–0.04) (87–153) (14.93–24.36) (107–204) (12.08–20.28) (−0.37 to −0.01)
Sri Lanka 0.69 3245 16.11 4189 16.20 0.01 1210 13.00 1539 13.10 0.01 2036 18.72 2650 18.73 0.00 1.43
(2926–3853) (14.57–19.27) (3009–5766) (11.67–22.22) (−0.27–0.35) (1041–1426) (11.31–15.19) (1040–2127) (8.9–18.02) (−0.31–0.36) (1767–2527) (16.31–23.74) (1883–3765) (13.37–26.47) (−0.28–0.36)
Turkey 0.748 10,722 15.32 12,071 13.45 −0.12 4568 13.35 5526 12.61 −0.06 6154 16.93 6544 14.06 −0.17 1.12
(9360–12,666) (13.36–18.02) (9272–16,054) (10.35–17.88) (−0.33–0.14) (3886–5552) (11.35–16.6) (4158–8042) (9.57–18.49) (−0.3–0.27) (5100–7361) (14.03–20.24) (4951–8494) (10.66–18.19) (−0.37–0.1)
Middle SDI
Armenia 0.689 327 8.97 578 14.43 0.61 141 8.99 242 14.03 0.56 186 8.87 336 14.62 0.65 1.04
(301–426) (8.3–11.6) (479–688) (11.99–17.07) (0.2–0.94) (124–217) (7.94–13.47) (198–292) (11.37–16.82) (−0.02–0.92) (168–208) (8.07–9.83) (272–405) (11.95–17.53) (0.31–0.98)
Azerbaijan 0.683 1070 12.97 1300 12.47 −0.04 391 10.10 518 10.48 0.04 679 15.38 782 14.15 −0.08 1.35
(918–1285) (11.21–16.09) (1033–1661) (9.96–16.22) (−0.2–0.16) (319–485) (8.21–12.64) (359–705) (7.42–13.99) (−0.21–0.35) (559–844) (12.87–19.69) (573–1048) (10.57–18.95) (−0.29–0.17)
China 0.686 160,968 10.37 187,319 9.70 −0.07 88,822 11.92 107,110 11.64 −0.02 72,146 9.21 80,208 8.11 −0.12 0.70
(14,3708–178,093) (9.27–11.43) (156,236–219,112) (8.11–11.27) (−0.21–0.09) (72,504–99,841) (9.63–13.3) (81,449–133,260) (8.91–14.29) (−0.22–0.2) (63,840–87,579) (8.18–11.1) (64,737–99,491) (6.55–10.07) (−0.29–0.08)
Indonesia 0.66 45,923 24.89 55,359 23.79 −0.04 14,358 15.93 19,316 16.95 0.06 31,565 33.10 36,043 30.02 −0.09 1.77
(32,903–53,740) (17.99–28.73) (40,142–67,329) (17.49–28.57) (−0.21–0.13) (11,456–17,244) (12.81–18.95) (14,091–25,688) (12.47–22.23) (−0.19–0.36) (18,835–38,661) (20.04–40.14) (22,173–46,237) (18.54–37.95) (−0.29–0.17)
Iran (Islamic Republic of) 0.67 6928 11.27 10,469 13.16 0.17 2851 9.15 4474 11.12 0.22 4076 13.43 5995 15.19 0.13 1.37
(5232–7503) (8.61–12.17) (6928–11,742) (8.93–14.62) (0.01–0.26) (2280–3050) (7.59–9.73) (3132–5029) (7.97–12.44) (0.04–0.34) (2873–4529) (9.71–14.89) (3638–6924) (9.52–17.42) (−0.04–0.25)
Iraq 0.671 3386 16.90 5290 19.13 0.13 1371 14.10 2309 17.24 0.22 2015 19.76 2981 21.12 0.07 1.23
(2583–4337) (12.94–21.71) (3807–6979) (14.14–24.62) (−0.11–0.42) (1010–1804) (10.42–18.35) (1638–3082) (12.46–22.32) (−0.08–0.62) (1466–2686) (14.52–26.16) (2047–4097) (14.96–28.14) (−0.2–0.41)
Philippines 0.623 21,800 33.39 29,535 34.27 0.03 7066 22.09 10,064 23.88 0.08 14,734 43.41 19,470 43.37 0.00 1.82
(19,658–24,027) (30.02–36.76) (23,648–35,586) (27.58–41.26) (−0.17–0.23) (6165–8033) (19.28–25.28) (7623–13,035) (18.17–30.75) (−0.19–0.4) (12,727–16,763) (37.67–49.51) (14,511–25,065) (32.54–55.48) (−0.23–0.28)
Syrian Arab Republic 0.619 543 4.44 619 4.62 0.04 272 4.19 312 4.51 0.08 271 4.81 307 4.79 0.00 1.06
(381–664) (2.93–5.45) (396–840) (2.99–6.27) (−0.23–0.37) (200–345) (2.97–5.41) (207–437) (3.03–6.22) (−0.22–0.49) (171–345) (2.71–6.11) (175–423) (2.69–6.52) (−0.26–0.31)
Thailand 0.687 11,838 15.88 13,375 13.40 −0.16 4121 11.61 5013 10.88 −0.06 7717 19.40 8362 15.45 −0.20 1.42
(9995–16,178) (13.52–21.16) (9579–19,927) (9.65–20.03) (−0.39–0.14) (3393–5324) (9.67–14.74) (3508–7664) (7.71–16.62) (−0.35–0.33) (6360–11,494) (16.1–28.01) (5898–13,949) (10.9–25.83) (−0.44–0.11)
Turkmenistan 0.67 396 10.95 550 12.05 0.10 176 9.99 256 11.40 0.14 220 11.70 294 12.50 0.07 1.10
(366–429) (10.19–11.81) (436–698) (9.6–15.28) (−0.12–0.39) (156–198) (8.91–11.13) (202–331) (8.99–14.62) (−0.11–0.46) (200–244) (10.71–12.85) (228–379) (9.78–16) (−0.17–0.36)
Uzbekistan 0.631 1020 6.21 1731 7.42 0.20 449 5.53 763 6.77 0.22 571 6.59 967 7.84 0.19 1.16
(947–1097) (5.74–6.68) (1429–2084) (6.07–8.77) (−0.01–0.42) (398–496) (4.86–6.13) (587–943) (5.02–8.22) (−0.02–0.51) (518–633) (5.95–7.23) (789–1175) (6.48–9.36) (−0.03–0.44)
Vietnam 0.617 29,405 37.74 36,453 36.32 −0.04 11,205 32.11 14,687 32.14 0.00 18,200 42.51 21,766 40.08 −0.06 1.25
(21,578–35,904) (29.3–45.44) (26,526–47,439) (27.08–46.92) (−0.24–0.19) (7248–13,888) (22.22–39.16) (9690–19,722) (22.11–41.97) (−0.24–0.27) (12,470–23,011) (30.34–52.94) (14,617–29,047) (27.31–52.85) (−0.27–0.19)
Low‐middle SDI
Bangladesh 0.483 16,099 14.80 19,906 13.76 −0.07 5910 10.88 7139 9.94 −0.09 10,189 18.99 12,766 17.59 −0.07 1.77
(12,379–21,148) (11.58–18.99) (14,232–28,069) (9.9–19.08) (−0.26–0.17) (4191–8019) (7.75–14.48) (4979–10,641) (6.96–14.74) (−0.33–0.2) (7391–14,873) (14.11–26.39) (8454–19,874) (11.75–27.01) (−0.3–0.23)
Bhutan 0.455 94 17.67 114 17.99 0.02 35 12.72 44 13.62 0.07 59 23.24 71 22.73 −0.02 1.67
(69–127) (13.31–23.85) (80–164) (12.9–25.45) (−0.18–0.24) (22–50) (8.11–18.33) (27–68) (8.4–20.47) (−0.17–0.36) (40–83) (16.44–32.14) (47–105) (15.64–32.9) (−0.23–0.23)
Cambodia 0.469 3012 31.56 4174 32.50 0.03 768 18.40 1106 19.68 0.07 2244 41.16 3068 42.02 0.02 2.14
(1944–3906) (20.61–40.45) (2685–5483) (20.95–42.23) (−0.16–0.26) (565–1022) (13.61–24.1) (781–1432) (14.09–25.11) (−0.17–0.35) (1323–2999) (24.34–54.07) (1719–4212) (23.89–56.81) (−0.17–0.3)
Democratic People's Republic of Korea 0.558 4392 16.02 4718 14.60 −0.09 1422 12.20 1718 11.71 −0.04 2970 19.19 3000 17.28 −0.10 1.47
(3318–5664) (12.3–20.48) (3560–6067) (11.06–18.82) (−0.25–0.12) (963–2156) (8.51–17.81) (1156–2473) (8.24–16.47) (−0.22–0.19) (2128–4096) (13.64–26.36) (2145–4158) (12.25–24.21) (−0.28–0.15)
India 0.566 173,924 17.32 217,465 17.20 −0.01 63,503 12.94 80,375 12.97 0.00 110,421 21.73 137,090 21.41 −0.01 1.65
(150,428–192,558) (15.07–19.19) (181,112–254,846) (14.37–20.14) (−0.16–0.15) (54,426–73,117) (10.99–14.85) (64,969–97,045) (10.48–15.62) (−0.2–0.25) (88,326–127,264) (17.45–25.06) (104,668–170,556) (16.41–26.51) (−0.21–0.21)
Kyrgyzstan 0.596 458 11.29 537 10.56 −0.06 134 6.99 170 6.98 0.00 324 14.63 367 13.31 −0.09 1.91
(420–495) (10.29–12.2) (454–637) (8.99–12.44) (−0.21–0.09) (119–150) (6.23–7.87) (139–205) (5.79–8.35) (−0.18–0.2) (288–359) (13.02–16.21) (298–443) (10.95–16) (−0.25–0.09)
Lao People's Democratic Republic 0.49 1116 29.39 1367 27.73 −0.06 324 17.16 417 17.10 0.00 792 40.77 950 37.74 −0.07 2.21
(710–1473) (18.88–38.16) (882–1838) (18.23–36.56) (−0.23–0.16) (221–435) (11.9–22.75) (291–556) (12.12–22.6) (−0.24–0.31) (428–1103) (22.82–55.46) (527–1334) (21.37–52.31) (−0.26–0.17)
Maldives 0.562 40 19.02 60 18.32 −0.04 26 23.40 43 23.34 0.00 13 13.82 17 12.30 −0.11 0.53
(35–45) (16.25–21.59) (49–74) (14.73–22.41) (−0.22–0.18) (22–31) (19.72–27.82) (34–55) (18.26–29.8) (−0.22–0.26) (10–16) (10.22–16.56) (13–22) (9.15–15.31) (−0.29–0.11)
Mongolia 0.606 291 16.73 390 15.02 −0.10 135 14.95 189 14.26 −0.05 156 17.80 201 15.17 −0.15 1.06
(140–369) (6.8–21.52) (184–526) (6.37–20.31) (−0.3–0.19) (63–179) (6.38–19.77) (87–264) (6.32–19.77) (−0.31–0.27) (65–207) (6.11–23.91) (86–285) (5.75–21.36) (−0.36–0.15)
Myanmar 0.521 11,022 27.89 12,605 25.52 −0.09 3133 17.29 3836 17.24 0.00 7889 36.58 8769 32.00 −0.13 1.86
(7630–14,080) (19.65–35.13) (9186–16,043) (18.89–32.17) (−0.26–0.14) (2263–4153) (12.76–22.96) (2815–4998) (12.72–22.5) (−0.23–0.31) (4791–10,399) (22.61–47.56) (5710–11,425) (20.98–41.44) (−0.32–0.1)
Palestine 0.588 276 14.37 444 16.59 0.15 81 8.58 121 9.02 0.05 194 19.22 323 23.53 0.22 2.61
(232–315) (12.03–16.38) (316–548) (11.76–20.3) (−0.11–0.42) (67–95) (7.03–10.17) (95–148) (7.11–10.95) (−0.17–0.31) (159–232) (15.58–22.7) (204–408) (14.81–29.53) (−0.13–0.56)
Tajikistan 0.539 213 5.27 290 5.35 0.01 103 5.06 144 5.28 0.04 110 5.46 146 5.39 −0.01 1.02
(164–249) (3.57–6.33) (216–364) (3.53–6.75) (−0.2–0.3) (73–124) (3.24–6.25) (102–185) (3.37–6.77) (−0.2–0.37) (79–131) (3.31–6.7) (107–187) (3.37–6.94) (−0.24–0.26)
Timor‐Leste 0.514 145 21.13 211 24.23 0.15 37 10.70 60 13.57 0.27 107 31.74 151 34.93 0.10 2.57
(92–195) (13.99–28.48) (138–286) (15.76–32.56) (−0.08–0.43) (24–57) (7.09–16.08) (38–85) (8.88–19.33) (−0.03–0.67) (64–150) (19.19–43.86) (89–212) (21.06–48.81) (−0.14–0.4)
Low SDI
Afghanistan 0.343 3166 24.93 4229 24.18 −0.03 766 12.65 1110 12.90 0.02 2400 36.33 3119 34.89 −0.04 2.70
(1784–4811) (15.1–37.14) (2421–6523) (15.22–35.44) (−0.21–0.22) (464–1282) (7.56–20.82) (706–1742) (8.22–19.93) (−0.21–0.34) (1081–3947) (17.9–58.19) (1471–5216) (18.18–54.8) (−0.24–0.22)
Nepal 0.422 3324 16.40 4680 18.69 0.14 977 10.25 1498 13.04 0.27 2347 22.20 3182 23.57 0.06 1.81
(2549–4373) (12.9–21.24) (3430–6331) (13.92–25.09) (−0.11–0.4) (629–1373) (6.67–14.29) (918–2188) (7.97–19.06) (−0.05–0.64) (1765–3257) (17.29–30.19) (2296–4500) (17.28–32.79) (−0.19–0.35)
Pakistan 0.449 38,327 33.09 49,409 32.29 −0.02 14,613 25.49 19,078 25.34 −0.01 23,714 41.17 30,331 39.53 −0.04 1.56
(31,722–45,824) (27.77–39.04) (39,271–60,858) (26.35–39.3) (−0.22–0.22) (11,327–18,156) (19.77–31.67) (13,760–25,597) (18.18–33.71) (−0.28–0.39) (17,633–30,706) (31.77–51.25) (21,162–42,069) (28.81–53.19) (−0.3–0.33)
Yemen 0.412 1567 13.17 2359 14.19 0.08 508 8.37 752 9.04 0.08 1059 18.00 1606 19.23 0.07 2.13
(1089–2159) (9.46–17.8) (1630–3283) (10.12–19.22) (−0.13–0.32) (346–757) (5.72–12.42) (490–1169) (5.92–14.05) (−0.18–0.39) (693–1573) (12.3–25.24) (1029–2365) (12.92–27.26) (−0.15–0.36)

3.4.5. National comparison

Among Asian countries, 31 countries experienced a decreasing trend in the ThC DALYs ASR between 2010 and 2019; the greatest increase was detected in Armenia (increase in DALYs ASR = 0.61 (95% CI: 0.20–0.94)) and the greatest decrease was detected in the Republic of Korea (decrease in DALYs ASR = −0.52 (95% CI: −0.59 to −0.12)) (Figure 2).

In 2019, the highest DALYs ASR (per 100,000) of ThC was reported in Vietnam (36.32), the Philippines (34.27), Cambodia (32.50), and Pakistan (32.29). The lowest DALYs ASR of ThC was reported in the Syrian Arab Republic (4.62), Tajikistan (5.35), Uzbekistan (7.42), and China (9.70).

In Asian men, the highest DALYs ASR (per 100,000) of ThC was reported in Vietnam (32.14), Pakistan (25.34), and the United Arab Emirates (24.00). The lowest DALYs ASR (per 100,000) of THC was reported in the Syrian Arab Republic (4.51), Tajikistan (5.28), Uzbekistan (6.77), and Kyrgyzstan (6.98).

In women, the highest DALYs ASR (per 100,000) of ThC was reported in the Philippines (43.37), Cambodia (42.02), Vietnam (40.08), Pakistan (39.53), and Lao People's Democratic Republic (37.74). The lowest DALYs ASR (per 100,000) of ThC was reported in the Syrian Arab Republic (4.79), Tajikistan (5.39), Uzbekistan (7.84), and China (8.11). Results in detail are presented in Table 8.

3.5. Male/female ratio

In 2010, only in Armenia, Maldives and China, the DALYs ASR of ThC in males was higher than in women. In 2019, the DALYs ASR of ThC in China, Maldives, and the United Arab Emirates were reported to be higher in men than in women. In other countries, the incidence of ThC in women was higher than in men. The highest ratio was reported in Bahrain (2.72‐fold) and the lowest ratio was recorded in Maldives (0.53‐fold) (Figure 3).

4. DISCUSSION

This study determined the time trend of the incidence, mortality, and burden of ThC from 2010 to 2019 in 49 Asian countries. Also, this time trend was determined based on geographic region and SDI and compared with global data. The results showed that from 2010 to 2019, the number of new cases of thyroid cancer increased 1.28 times, the number of deaths increased 1.26 times, and the prevalence of thyroid cancer increased 1.39 times. In contrast, thyroid cancer's DALY increased 1.2 times. Also, from 2010 to 2019, ASIR increased by 5%, ASDR decreased by 6%, ASPR increased by 16%, and Dalys ASR of ThC cancer decreased by 4%.

The results showed that in 2019, more than 54% of ThC cases occurred in Asian countries. In 2019, more than 31.5% of new ThC cases occurred in men, and more than 68.5% of new cases occurred in Asian women. From 2010 to 2019, the number of new cases increased by 1.25 times in women and men by 1.38. In the investigated Asian countries, from 2010 to 2019, ASIR of ThC increased by 5%. This increase was higher in men than in women (5% vs. 3%). In this period, ASIR of ThC increased globally and in Africa, but in America and Europe, it decreased.

According to the results, in 2019, the newest cases of ThC were reported in men and women +85. In the same year, the highest ASIR of ThC was generally observed in high‐income Asia‐Pacific countries. Also, ASIR of ThC was higher in males than females in Maldives and more elevated in females than males in other countries.

The incidence of thyroid cancer varies significantly based on geographic location, especially in women. 18 The highest incidence is observed in high‐income countries such as the Republic of Korea, Canada, Italy, France, Israel, Croatia, Austria, the United States, and some middle‐to‐high‐income countries such as Turkey, Brazil, Costa Rica, and China. 18 , 19 It is high in some countries and island regions, including Cyprus, Cape Verde, French Polynesia, New Caledonia, and Puerto Rico. 18 This variation appears to be mainly attributable to geographic differences in access to care and diagnostic procedures, although environmental exposures may also play a role. 20

Many exogenous factors are related to the development of thyroid cancer, the most important of which are iodine deficiency and radiation, but other factors may also play a role in the development of this disease, including diet, exposure to endocrine‐disrupting chemicals (EDCs) or xenobiotics, or other related influences from volcanic areas. 21

The best‐studied risk factor for differentiated thyroid carcinomas is radiation exposure, which increases the risk of thyroid malignancy from 5% to 50%. 17 , 22 Other risk factors include estrogen, 23 smoking, 24 diabetes, 25 insulin resistance, 26 obesity, 27 metabolic syndrome,28 insulin resistance, 23 and physical activity. 29 In a population‐based cohort study conducted in Korea, smoking and alcohol were shown to be inversely associated with thyroid cancer, with a significant interaction between these variables. 30

The results showed that in 2019, more than 59% of ThC deaths occurred in Asian countries. The number of ThC deaths in 2019 increased by 1.26 times, but the ASDR of ThC decreased by 6%. From 2010 to 2019, the number of deaths in men increased by 1.29 times and women by 1.24 times. In the investigated Asian countries, from 2010 to 2019, the ASDR of THC decreased by 6%. This decrease was more significant in women than men (8% vs. 2%). ThCs ASDR declined in America, Europe, and globally during this period, while it has been stable in Africa. Death from thyroid cancer is related to age, gender, and stage of the disease. Age is an important risk factor for death. 31 According to the results of this study, most cases of ThC death were reported in women and men aged 85 and older. Also, in most age groups, death cases of ThC were higher in women than in men. Males have been shown to have more prolonged survival than females. 31 Also, in most studies, age has been reported as one of the most critical and influential risk factors for disease survival in ThC patients. 32 It should be noted that the 5‐year survival rate of ThC is generally 98.1%. 33 Fortunately, the 5‐year survival of ThC is high, so if the prevalence of thyroid cancer is high, it can be due to the increase in new cases or the high survival rate of thyroid cancer.

From 2010 to 2019, according to the results, the number of cases living with ThC increased by 1.3 times. In 2019, more than 53% of ThC prevalence occurred in Asian countries. The number of patients who lived with ThC has risen 1.39 times in men and 1.25 times in women. Also, the ASPR of ThC increased by 8% in the period under review. ASPR of ThC increased in Asian men and women from 2010 to 2019, but this increase was more tremendous in men than in women, with a 16% increase in men and a 5% increase in women. ThC ASDR increased globally and in Africa during this period, but this amount decreased in America and Europe. The highest age‐specific prevalence of cases of ThC were reported in men aged 55 to 59 and women aged 60 to 64. Also, in all age groups, the prevalence of cases of ThC was higher in women than in men.

In this review, ThC DALYs were also evaluated. The results showed that ThC DALYs increased 1.2 times from 2010 to 2019. Also, in 2019, about 61% of ThC DALYs occurred in Asian countries. During this period, Dalys ASR of ThC decreased by 4%. DALY ASR of ThC decreased in men and women, although this reduction was greater in women than in men, so it decreased by 6% in women and 2% in men. This amount decreased globally and in Europe, while it increased in America and Africa. Also, DALY cases of ThC in most age groups (except 80–84 years old and 85 years old and above) were more in women than in men.

The relationships between gender, obesity, and ThC have been widely investigated. 34 Worldwide, obesity and ThC are more common in women than men. 23 , 35 The results of a meta‐analysis showed that obesity is associated with ThC. 36 It has also been shown that the body mass index is higher in women than men. 37 , 38 , 39 , 40 On the other hand, hyperinsulinemia, as a result of insulin resistance, is associated with obesity and has been suggested as a link between obesity and cancer development. 41 , 42 , 43 The prevalence of diabetes is also higher in women than in men. 37 , 38 , 39 , 40 Therefore, it can be said that obesity and diabetes are related to the higher prevalence of ThC in women.

In this study, also we have conducted further analysis, specifically focusing on the differentiation between the elderly and non‐elderly groups. The results showed that 48.13% of new cases of ThC was in elderly aged ≥70 years in Asia. Also, 55.61% of THC deaths, 40.24% of ThC patients, and 55.87% of the burden caused by ThC were recorded in the elderly aged ≥70 years in Asia. It should be noted that ThC is the only malignancy in which age increase is considered a prognostic indicator in the majority of staging systems. 44 Although the mortality rate starts to climb at age 45, the rate of recurrence is even higher starting at age 60. 44

A higher cancer recurrence rate has been demonstrated in children and young adults aged over 20, but with a better survival rate over the evaluable time period. 45 In another study, it was found that participants who were 70 years or older were more likely to die from thyroid cancer and that the proportion of death increased by years 46 The decrease in death among other age groups may be due to improved treatment and aging of the population. 47

The responsiveness to radioactive iodine (RAI) is related to better survival in young individuals. 48 , 49 According to another study, the 5‐year survival rate for younger, older, and super‐elders was 90.3%, 76.8%, and 57.8%, respectively. 50 Alternatively, elderly patients have a tendency to present at advanced stages and have more aggressive histology. 51 So, ThC death in this age group is higher other groups.

Age is associated with changes in thyroid physiology, including a rise in thyroid‐stimulating hormone (TSH) and a drop in the rate of thyrocyte proliferation. Aging has a negative impact on both normal thyroid tissue and thyroid cancer, and those older than 45 have a worse prognosis. 52

Again, ThC stands out from other malignancies in that age is a significant predictor in most staging systems. Preventing premature death is greatly assisted by early detection and screening.

It should be considered that timely interventions are necessary to prevent ThC, especially in women and people at risk. On the other hand, the effect of ThC screening should be considered. However, there are no direct studies on whether screening causes overdiagnosis; ecological and cross‐sectional data suggest that ThC screening leads to an increase in disease incidence without a change in mortality. 53 The conclusion of a systematic review in the United States showed that the incidence of ThC is increasing over time without changing the mortality rate. 54 Finally, it should be kept in mind that although the survival of ThC is high, ThC is the most common endocrine cancer in the world, leading to a significant burden of this disease.

5. CONCLUSION

More than half of the burden of ThC is imposed on the residents of the Asian continent. Although the incidence and prevalence of this cancer in Asian countries is lower than that of the world, America, and Europe, the highest rate of death from ThC occurs in Asia and they witness the highest burden of the disease. Therefore, it seems that implementing early detection strategies and increasing access to treatment facilities in Asia is one of the necessities of ThC control in its residents.

6. LIMITATION

Given the difficulties of using online databases, including the quality of data reported by low‐income countries, the results of this study should be interpreted with caution.

AUTHOR CONTRIBUTIONS

AM, HS, FR, and LA designed and conceived the study. AM and ZP collected the data. LA, AM, HS, and ZP analyzed the data. AM, SD, FR, LA, and ZP drafted the manuscript. HS and AM provided administrative support. FR and AM provided oversight. All authors contributed to the article and approved the submitted version.

ACKNOWLEDGEMENTS

N/A.

FUNDING INFORMATION

This research received no external funding.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

ETHICS STATEMENT

The study was approved by the ethics committee of the Jahrom University of Medical Sciences (ethics committee approval code IR.JUMS.REC.1401.094). As we used routinely collected anonymized electronic data, patient consent was not required. All procedures were performed by the relevant guidelines and regulations.

Rezaei F, Mazidimoradi A, Pasokh Z, Dehghani SP, Allahqoli L, Salehiniya H. Temporal trends of thyroid cancer between 2010 and 2019 in Asian countries by geographical region and SDI, comparison with global data. Aging Med. 2023;6:386‐426. doi: 10.1002/agm2.12277

DATA AVAILABILITY STATEMENT

The data presented in this study are available on request from the corresponding author.

REFERENCES

  • 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394‐424. [DOI] [PubMed] [Google Scholar]
  • 2. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:1‐10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Fitzmaurice C, Dicker D, Pain A, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505‐527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209‐249. [DOI] [PubMed] [Google Scholar]
  • 5. Bonnefond S, Davies TF. Thyroid cancer—risks and causes. Oncol Hematol Rev. 2014;10:144‐151. [Google Scholar]
  • 6. Horvatic Herceg G, Herceg D, Kralik M, et al. Urokinase plasminogen activator and its inhibitor type‐1 as prognostic factors in differentiated thyroid carcinoma patients. Otolaryngol Head Neck Surg. 2013;149(4):533‐540. [DOI] [PubMed] [Google Scholar]
  • 7. Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646‐653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Hiasa Y, Kitahori Y, Kitamura M, et al. Relationships between serum thyroid stimulating hormone levels and development of thyroid tumors in rats treated with N‐bis‐(2‐hydroxypropyl) nitrosamine. Carcinogenesis. 1991;12(5):873‐877. [DOI] [PubMed] [Google Scholar]
  • 9. Cherrat L, Espina L, Bakkali M, García‐Gonzalo D, Pagán R, Laglaoui A. Chemical composition and antioxidant properties of Laurus nobilis L. and Myrtus communis L. essential oils from Morocco and evaluation of their antimicrobial activity acting alone or in combined processes for food preservation. J Sci Food Agric. 2014;94(6):1197‐1204. [DOI] [PubMed] [Google Scholar]
  • 10. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body‐mass index and incidence of cancer: a systematic review and meta‐analysis of prospective observational studies. Lancet. 2008;371(9612):569‐578. [DOI] [PubMed] [Google Scholar]
  • 11. Choi WJ, Kim J. Dietary factors and the risk of thyroid cancer: a review. Clin Nutr Res. 2014;3(2):75‐88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136(9):2187‐2195. [DOI] [PubMed] [Google Scholar]
  • 13. Allahqoli L, Mazidimoradi A, Momenimovahed Z, et al. The global incidence, mortality, and burden of breast cancer in 2019: correlation with smoking, drinking, and drug use. Front Oncol. 2022;12:921015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Momenimovahed Z, Mazidimoradi A, Amiri S, Nooraie Z, Allahgholi L, Salehiniya H. Temporal trends of cervical cancer between 1990 and 2019, in Asian countries by geographical region and socio‐demographic index, and comparison with global data. Oncologie. 2023;25(2):119‐148. [Google Scholar]
  • 15. Momenimovahed Z, Mazidimoradi A, Banakar N, Allahqoli L, Salehiniya H. Temporal trends of ovarian cancer between 1990 and 2019, in Asian countries by geographical region and SDI, comparison with global data. Indian J Gynecol Oncol. 2023;21(2):38. [Google Scholar]
  • 16. Rezaei F, Mazidimoradi A, Rayatinejad A, Allahqoli L, Salehiniya H. Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data. Thorac Cancer. 2023;14:1668‐1706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Mazidimoradi A, Ghavidel F, Momenimovahed Z, Allahqoli L, Salehiniya H. Global incidence, mortality, and burden of esophageal cancer, and its correlation with SDI, metabolic risks, fasting plasma glucose, LDL cholesterol, and body mass index: An ecological study. Health Sci Rep. 2023;6(6):e1342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; 2018. [Google Scholar]
  • 19. Lortet‐Tieulent J, Franceschi S, Dal Maso L, Vaccarella S. Thyroid cancer “epidemic” also occurs in low‐and middle‐income countries. Int J Cancer. 2019;144(9):2082‐2087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Pizzato M, Li M, Vignat J, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264‐272. [DOI] [PubMed] [Google Scholar]
  • 21. Nettore IC, Colao A, Macchia PE. Nutritional and environmental factors in thyroid carcinogenesis. Int J Environ Res Public Health. 2018;15(8):1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Iglesias ML, Schmidt A, Ghuzlan AA, et al. Radiation exposure and thyroid cancer: a review. Arch Endocrinol Metab. 2017;61:180‐187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Derwahl M, Nicula D. Estrogen and its role in thyroid cancer. Endocr Relat Cancer. 2014;21(5):T273‐T283. [DOI] [PubMed] [Google Scholar]
  • 24. Cho YA, Kim J. Thyroid cancer risk and smoking status: a meta‐analysis. Cancer Causes Control. 2014;25:1187‐1195. [DOI] [PubMed] [Google Scholar]
  • 25. Yeo Y, Ma S‐H, Hwang Y, et al. Diabetes mellitus and risk of thyroid cancer: a meta‐analysis. PloS One. 2014;9(6):e98135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Xu N, Liu H, Wang Y, Xue Y. Relationship between insulin resistance and thyroid cancer in Chinese euthyroid subjects without conditions affecting insulin resistance. BMC Endocr Disord. 2022;22(1):58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Burrage LC, McLeod DS, Jordan SJ. Obesity and thyroid cancer risk. Curr Opin Endocrinol Diabetes Obes. 2023;30(5):244‐251. [DOI] [PubMed] [Google Scholar]
  • 28. Park JH, Cho HS, Yoon JH. Thyroid cancer in patients with metabolic syndrome or its components: a nationwide population‐based cohort study. Cancer. 2022;14(17):4106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Bui AQ, Gunathilake M, Lee J, Lee EK, Kim J. Relationship between physical activity levels and thyroid cancer risk: a prospective cohort study in Korea. Thyroid. 2022;32(11):1402‐1410. [DOI] [PubMed] [Google Scholar]
  • 30. Yeo Y, Shin DW, Han K, et al. Smoking, alcohol consumption, and the risk of thyroid cancer: a population‐based Korean cohort study of 10 million people. Thyroid. 2022;32(4):440‐448. [DOI] [PubMed] [Google Scholar]
  • 31. Amri A, Soltanian AR, Borzouei S. Survival rates and prognostic factors of thyroid cancer: a retrospective cohort study. J Parathyr Dis. 2022;10(1):e11162. [Google Scholar]
  • 32. Kaliszewski K, Diakowska D, Nowak Ł, Wojtczak B, Rudnicki J. The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice. BMC Cancer. 2020;20(1):1‐11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Bibbins‐Domingo K, Grossman DC, Curry SJ, et al. Screening for thyroid cancer: US preventive services task force recommendation statement. JAMA. 2017;317(18):1882‐1887. [DOI] [PubMed] [Google Scholar]
  • 34. Pappa T, Alevizaki M. Obesity and thyroid cancer: a clinical update. Thyroid. 2014;24(2):190‐199. [DOI] [PubMed] [Google Scholar]
  • 35. Kautzky‐Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278‐316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Ma J, Huang M, Wang L, Ye W, Tong Y, Wang H. Obesity and risk of thyroid cancer: evidence from a meta‐analysis of 21 observational studies. Med Sci Monit. 2015;21:283‐291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Rezaei F, Seif M, Gandomkar A, Fattahi MR, Hasanzadeh J. Agreement between laboratory‐based and non‐laboratory‐based Framingham risk score in southern Iran. Sci Rep. 2021;11(1):10767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Rezaei F, Seif M, Gandomkar A, et al. Comparison of laboratory‐based and non‐laboratory‐based WHO cardiovascular disease risk charts: a population‐based study. J Transl Med. 2022;20(1):1‐9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Jahangiry L, Dehghan A, Farjam M, Aune D, Rezaei F. Laboratory‐based and office‐based Globorisk scores to predict 10‐year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort. BMC Med Res Methodol. 2022;22(1):305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Dehghan A, Rayatinejad A, Khezri R, Aune D, Rezaei F. Laboratory‐based versus non‐laboratory‐based World Health Organization risk equations for assessment of cardiovascular disease risk. BMC Med Res Methodol. 2023;23(1):1‐12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Noto H, Tsujimoto T, Sasazuki T, Noda M. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta‐analysis. Endocr Pract. 2011;17(4):616‐628. [DOI] [PubMed] [Google Scholar]
  • 42. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol. 2006;207(1):12‐22. [DOI] [PubMed] [Google Scholar]
  • 43. Van Den Brandt PA, Spiegelman D, Yaun S‐S, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514‐527. [DOI] [PubMed] [Google Scholar]
  • 44. Edge SB, Byrd D, Compton C, Fritz A, Greene F, Trotti A. American joint committee on Cancer cancer staging manual. Ann Surg Oncol. 2010;17:1471‐1474. [DOI] [PubMed] [Google Scholar]
  • 45. Miccoli P, Minuto MN, Ugolini C, et al. Papillary thyroid cancer: pathological parameters as prognostic factors in different classes of age. Otolaryngol Head Neck Surg. 2008;138(2):200‐203. [DOI] [PubMed] [Google Scholar]
  • 46. Deng Y, Li H, Wang M, et al. Global burden of thyroid cancer from 1990 to 2017. JAMA Netw Open. 2020;3(6):e208759‐e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Lee R, Mason A, Members of the NTA Network . Is low fertility really a problem? Population aging, dependency, and consumption. Science. 2014;346(6206):229‐234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Ronga G, Filesi M, Montesano T, et al. Lung metastases from differentiated thyroid carcinoma. QJ Nucl Med Mol Imaging. 2004;48:12‐19. [PubMed] [Google Scholar]
  • 49. Jarzab B, Handkiewicz‐Junak D, Włoch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer. 2005;12(4):773‐803. [DOI] [PubMed] [Google Scholar]
  • 50. Sahli ZT, Canner JK, Zeiger MA, Mathur A. Association between age and disease specific mortality in medullary thyroid cancer. Am J Surg. 2021;221(2):478‐484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Biliotti G, Martini F, Vezzosi V, et al. Specific features of differentiated thyroid carcinoma in patients over 70 years of age. J Surg Oncol. 2006;93(3):194‐198. [DOI] [PubMed] [Google Scholar]
  • 52. Haymart MR. Understanding the relationship between age and thyroid cancer. Oncologist. 2009;14(3):216‐221. [DOI] [PubMed] [Google Scholar]
  • 53. Lin JS, Bowles EJA, Williams SB, Morrison CC. Screening for thyroid cancer: updated evidence report and systematic review for the US preventive services task force. JAMA. 2017;317(18):1888‐1903. [DOI] [PubMed] [Google Scholar]
  • 54. Lin JS, Aiello Bowles EJ, Williams SB, Morrison CC. Screening for Thyroid Cancer: A Systematic Revidence Review for the US Preventive Services Task Force. Agency for Healthcare Research and Quality; 2017. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.


Articles from Aging Medicine are provided here courtesy of Wiley

RESOURCES